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AbsTrACT
background
Lifestyle factors have been shown to influence the incidence of fatal and non-fatal cardiovascular 
diseases (CVD). A healthy diet, being physically active, moderate alcohol consumption and 
not smoking are associated with a lower CVD risk. In addition to these lifestyle factors, recent 
research suggests that poor sleep may also be a risk factor of CVD. In this thesis, we focused on a 
Mediterranean style diet, specific leisure time physical activities, and sleep duration and quality as 
risk factors of CVD.
Methods
Our analyses are based on the prospective Doetinchem Cohort Study (n~3,400), the Monitoring 
Project on Risk Factors for Chronic Diseases (MORGEN) Study (n~20,400) and the Dutch contribution 
to the European Prospective Investigation into Cancer and Nutrition (EPIC-NL) (n~34,700). These 
studies included men and women aged 20–65 years when examined between 1993 and 1997. Diet 
was assessed with the validated EPIC food frequency questionnaire and operationalized with the 
Mediterranean Diet Score (MDS, range: 0–9). Physical activity was estimated with the validated EPIC 
physical activity questionnaire, with an emphasis on different leisure time activities. In addition, 
information was collected on duration and quality of sleep by two questions. Cardiovascular morbidity 
and mortality were ascertained through linkage with national registers. Multivariable Cox models 
were used to estimate the strength of the associations and 95% confidence intervals.
results
During 12 years of follow-up, 206 CVD cases occurred in the Doetinchem Cohort Study, 1,486 cases in the 
MORGEN Study and 4,881 cases in the EPIC-NL Study. In the study on diet, a two unit increment in MDS 
was associated with a 22% lower risk of fatal CVD, and a 5% lower risk of total CVD. For specific CVDs, a 
14% lower risk of myocardial infarction, a 12% lower risk of stroke, and a 26% lower risk of pulmonary 
embolism was observed. The MDS was not related to incident angina pectoris, transient ischemic attack 
and peripheral arterial disease. The use of multiple measurements of the MDS increased the strength of 
the associations with CVD and narrowed the confidence intervals. For leisure time physical activity, we 
showed that cycling was associated with an 18% lower risk of total CVD, sports with a 26% lower risk, 
and those who both cycled and performed sports had a 34% lower risk. Walking and gardening were 
not associated with CVD risk. Short sleep duration was associated with a 15% higher risk of total CVD, 
whereas long sleep duration and sleep quality separately were not associated. Short sleepers with a 
poor sleep quality had a 63% higher risk of total CVD compared to those with a normal sleep duration 
and good sleep quality. Finally, the combination of a healthy diet, sufficient physical activity, moderate 
alcohol consumption and non-smoking was associated with a 57% lower risk of composite CVD and a 
67% lower risk of fatal CVD. The addition of sufficient sleep duration to these four traditional healthy 
lifestyle factors resulted in a 65% lower risk of composite CVD and an 83% lower risk of fatal CVD.
Conclusions 
In this thesis, we showed that the strength of the association between dietary patterns and CVD 
incidence is likely underestimated because most studies used only the baseline measurement 
of diet. Furthermore, leisure time physical activities should be of at least moderate intensity to 
contribute to lower CVD risk. We also observed that sufficient sleep is a factor that should be taken 
into consideration in the prevention of CVD, in combination with a healthy diet, sufficient physical 
activity, moderate alcohol consumption and not smoking. Our results underscore the importance 
of a healthy lifestyle for CVD prevention.
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Cardiovascular diseases (CVD) are the second cause of death in The Netherlands. In 2010, 
29% of deaths was due to CVD; 21,154 women and 18,581 men died from CVD (Figure 1.1).1 
Although CVD mortality rates in The Netherlands are continuously decreasing, the relatively 
low CVD mortality is accompanied by a high CVD incidence and prevalence. In 2007, there were 
648,300 prevalent cases of coronary heart disease and 191,000 prevalent cases of stroke. In 
that year, 82,100 incident cases of coronary heart disease cases occurred and 35,600 incident 
cases of stroke.2 Because of this large number of prevalent and incident cases, primary and 
secondary prevention of CVD is from a public health perspective of utmost importance.
Lifestyle factors and CVD risk
Evidence is strong that lifestyle factors influence the incidence of fatal and non-fatal CVD. 
Adhering to a healthy diet, being physically active, non-smoking and moderate alcohol 
consumption are associated with a low CVD risk.3 Stampfer et al. estimated that over 70% of 
stroke cases and over 80% of coronary heart disease cases may be prevented or postponed by 
a healthy lifestyle.4 In addition to the lifestyle factors mentioned, more recent research showed 
that poor sleep may also be an independent risk factor of CVD.5,6 
Figure 1.1 Age standardized trends in total CVD mortality in The Netherlands (per 100,000), by gender. 
Year of standardization is 2010 (source: Statistics Netherlands/ Netherlands Heart Foundation).1 
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Mediterranean style diet and CVD risk
In the 1960’s, Keys et al. showed in the Seven Countries Study that the population of the Greek 
island of Crete had a low rate of coronary heart disease and a long life expectancy. The traditional 
Mediterranean diet in Crete was considered to be largely responsible for this.7 This diet is often 
defined as the dietary pattern found in the olive growing areas of the Mediterranean region, 
during the late 1950s and early 1960s. This was a period when the consequences of World 
War II had been overcome, but the fast-food culture had not yet invaded the area.8 The diet is 
characterized by the use of olive oil as the principal component of fat; relatively high consumption 
of fruits, vegetables, fish, whole grains, legumes, and nuts; low consumption of meat and dairy; 
and moderate alcohol consumption with meals.9,10 It is often seen as a prototype of a healthy 
dietary pattern. A recent meta-analysis by Sofi et al. showed that each two-unit increment of a 
nine-point score measuring the adherence to a Mediterranean style diet, was associated with 
a 10% lower incidence of CVD.11 
CVD consists of various diseases. Each has a different etiology and ideally should be investigated 
individually in relation to dietary patterns. We hypothesized that adherence to Mediterranean 
style diets is inversely related to all of the following CVD endpoints: myocardial infarction, 
angina pectoris, stroke, transient ischemic attack, peripheral arterial disease, and pulmonary 
embolism, but that the strength of these inverse relationships differs. 
In chapter 2 we describe the association of a Mediterranean style diet, as a prototype 
of a healthy diet with different types of incident CVD.
The strength of the association between a Mediterranean style diet and CVD may be 
underestimated since in most cohort studies only a single measurement of dietary intake is 
available. Multiple measurements of dietary intake over a longer period of time can theoretically 
strengthen the observed associations because averaging multiple measurements reduces 
random measurement error and multiple measurements over a longer period better represent 
long-term dietary patterns.12,13 Studies on the effect of repeatedly estimated dietary patterns 
on the association with CVD have not been carried out so far. We hypothesized that multiple 
measurements of diet would increase the strength of the association with CVD compared to 
the baseline measurement.
In chapter 3 we report the strength of the association between a Mediterranean 
style diet and CVD incidence, comparing three repeated measurements to the 
baseline measurement. 
Physical activity and CVD risk
Many epidemiological studies have shown a clear inverse association between physical activity 
and CVD.14,15 A recent meta-analysis included 21 prospective studies with more than 650,000 
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adults initially free from CVD. Among men, a 24% lower risk of total CVD (RR: 0.76 [95% CI: 
0.70–0.82]) and among women a 27% lower risk (RR: 0.73 [0.68–0.78]) was observed for high, 
compared to a low level of leisure time physical activity. Also dose-response relationships were 
observed.16 In The Netherlands, as in many countries worldwide, physical activities of at least 
moderate intensity (at least 4.0 MET) during at least 30 minutes a day on at least 5 days a week 
are recommended.17 In 2011, 58% of the Dutch adult population adhered to this guideline.18
The Dutch are among the most physically active populations in Europe and worldwide.19,20 Of 
nine European countries, people from The Netherlands dedicated most time to non-occupational 
physical activity.19 Furthermore, of the 16 countries – amongst others Australia, USA, China, Brazil, 
Canada, New Zealand and European countries – included in a recent review, the Dutch were the 
second most active with regard to walking or cycling to work.20 It was recently estimated that 
worldwide 5.8% (95% CI: 3.2–7.8) of the burden of disease from coronary heart disease could 
be prevented if all would adhere to the physical activity guidelines.21 For The Netherlands it 
was estimated that 3.0% (95% CI: -0.1–7.1) of coronary heart disease cases could be prevented. 
This preventable proportion is relatively low compared to some other countries; in the USA, for 
instance, it has been estimated to be 6.7%.21 
Much less is known about the association of specific types of leisure time physical activity in 
relation to CVD. In this thesis we focused on walking and activities of at least moderate intensity, 
in particular gardening, cycling and sports.  Although walking at an average speed (3.5 METs) 
does not classify as ‘moderate intense’ activity in The Netherlands, this type of physical activity 
has repeatedly been associated with a lower risk of CVD.22-24 Though gardening on average 
has a moderate intensity (4.0 MET), studies on gardening and CVD risk are lacking. Cycling, a 
frequently used means of transportation in The Netherlands, contributes substantially to the 
activity level of Dutch people. It was associated with a 9–28% lower risk of CVD in previous 
studies.25 It should be noted that none of these investigations were conducted in a population 
where cycling is a common means of transportation. The protective association of sports 
with CVD has been shown repeatedly.26-30 We hypothesized that walking, gardening, cycling, 
and sports are inversely related to CVD incidence but that the strengths of these inverse 
relationships differ. 
In chapter 4 we describe the results of a study on the relation between specific 
types of leisure time physical activity (walking, gardening, cycling and sports) and 
CVD incidence. 
Sleep and CVD risk
How much sleep does a human being need? This question has intrigued researchers for 
decades. Already in 1964, Hammond reported in a cohort study including 461,440 men that 
those sleeping about 7 hours per night had a lower death rate than men who slept either 
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more or less hours. A recent meta-analysis by Cappuccio et al. incorporated 15 cohort studies, 
and showed that short sleep duration was associated with a 48% greater risk of CHD and a 
15% higher risk of stroke, but it was not associated with total CVD.6 Also for long compared to 
normal sleep duration they reported a 38% higher risk of CHD, a 65% higher risk of stroke, and 
a 41% higher risk of total CVD.6 
Not only the duration but also the quality of sleep may affect health. Sleep quality is an important 
factor in the physiologic recovery of the body during sleep.31 This raises the question whether 
short sleepers who rise every morning feeling rested, are at the same cardiovascular risk as 
short sleepers who wake up still feeling tired. It could be that the first group did not need more 
hours to sleep because they slept ‘efficiently’. Chandola et al. showed in the Whitehall II cohort 
that the negative effect of short sleep duration on CHD risk was greatest among those with 
sleep disturbance.32 We therefore hypothesized that short sleep duration may be adequate for 
those with a good sleep quality, but not for those with a poor sleep quality. 
In chapter 5 we describe the association of sleep duration and sleep quality with 
CVD incidence.
Combined lifestyle factors and CVD risk
Besides diet,11 physical activity,16 and sleep,6 also smoking33,34 and alcohol consumption35 
are strongly associated with CVD. The Nurses Health Study showed that, compared to never 
smokers, current smokers had a four times higher risk, and former smokers had a 50% higher 
risk of fatal and non-fatal CHD combined.36 Similar results were observed in other studies.34,37,38 
Streppel et al. observed in Dutch men that cigarette smoking reduced the number of disease-
free life-years by 5.8 years, and cigar or pipe smoking by 5.2 years.39 For alcohol consumption, 
a recent meta-analysis by Ronksley et al. showed a U-shaped association with fatal CVD, an 
L-shaped association with fatal and non-fatal CHD, and a J-shaped association with fatal and 
non-fatal stroke.35 Moderate alcohol consumption was also associated with a 2.3 year longer 
life expectancy at age 50 compared to never drinking.40 Given the already available strong 
evidence for smoking and drinking in relation to CVD risk and survival, we did not investigate 
these associations separately in this thesis.
The lifestyle factors diet, physical activity, smoking and alcohol consumption tend to cluster in 
individuals.41-47 In the MORGEN-Study about 20% of the population had at least three out of four 
unhealthy lifestyle factors.41 To take clustering of lifestyle factors into account, several studies 
investigated different combinations of lifestyle factors in relation to CVD incidence.4,48-57 Hazard 
ratios for the highest compared with the lowest degrees of adherence to a healthy lifestyle ranged 
from 0.24 to 0.35 for fatal CVD.48-51,54-56 Only two studies included sleep duration as a lifestyle 
factor.48,54 Both studies were performed in Asian populations and assessed the associations of 
the combination of sleep and the other four lifestyle factors with CVD, without providing insight 
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into the additional impact of sleep over the other healthy lifestyle factors.48,54 We hypothesized 
that – in addition to a healthy diet, sufficient physical activity, moderate alcohol consumption, 
and non-smoking – sufficient sleep duration further lowers the risk of CVD.
In chapter 6 we describe whether sufficient sleep duration – in addition to a healthy 
diet, sufficient physical activity, moderate alcohol consumption, and non-smoking 
– contributed to lower CVD incidence.
Study populations 
Figure 1.2 summarizes the characteristics of the populations used for the analyses presented 
in this thesis. The EPIC-NL cohort is the Dutch contribution to the European Prospective 
Investigation into Cancer and Nutrition (EPIC) and consists of the Monitoring Project on Risk 
Factors for Chronic Diseases (MORGEN) and the PROSPECT cohort. Baseline data of the 40,011 
participants in the EPIC-NL cohort were collected between 1993 and 1997. The MORGEN 
cohort consists of 22,654 men and women aged 20–65 years who were recruited through 
random population sampling in three towns in The Netherlands (Amsterdam, Maastricht and 
Doetinchem).58 In the MORGEN cohort the participants from Doetinchem had already been 
examined five years before, and were subsequently examined every five years as part of the 
Doetinchem Cohort Study.59 About 4,000 persons participated in the last three rounds of this 
study and the fifth examination round has just been finished.
Figure 1.2 Study populations in this thesis.
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Outline
Though much is known about the relation between lifestyle factors and risk of CVD, details 
regarding the nature of this relation are lacking. This thesis provides more information on some 
of these details. We investigated the associations of a Mediterranean style diet with different 
subgroups of CVD (chapter 2), and the additional value of repeated measurements of this diet 
in estimating the strength of the association with CVD incidence (chapter 3). With respect to 
physical activity, we studied specific types of leisure time physical activity in relation to CVD 
incidence (chapter 4). In addition, we studied sleep duration and sleep quality in relation to CVD 
incidence (chapter 5), and also the contribution to lower CVD risk of sufficient sleep duration – in 
addition to a healthy diet, sufficient physical activity, moderate alcohol consumption, and non-
smoking (chapter 6). Finally, we discussed the results of the different studies with an emphasis 
on methodological aspects and public health implications (chapter 7).
ReFeReNCeS
1.  Vaartjes I, van Dis I, Visseren FLJ, Bots ML. Hart- en vaatziekten in Nederland bij vrouwen en mannen. 
In: Vaartjes I, van Dis I, Visseren FLJ, Bots ML. Hart- en vaatziekten in Nederland 2011, cijfers over 
leefstijl- en risicofactoren, ziekte en sterfte. Den Haag: Hartstichting, 2011.
2. Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid. Bilthoven: RIVM.  http://
www.nationaalkompas.nl, 2012.
3. Haskell WL. Cardiovascular disease prevention and lifestyle interventions: effectiveness and efficacy. 
J Cardiovasc Nurs. 2003;18(4):245-255.
4. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease 
in women through diet and lifestyle. N Engl J Med. 2000;343(1):16-22.
5. Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, van den Berg JF, Verschuren WM. Sleep Duration 
and Sleep Quality in Relation to 12-Year Cardiovascular Disease Incidence: The MORGEN Study. Sleep. 
2011;34(11):1487-1492.
6. Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular 
outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32:1484-
1492.
7. Keys A, Menotti A, Karvonen MJ, et al. The diet and 15-year death rate in the seven countries study. 
Am J Epidemiol. 1986;124(6):903-915.
8. Panagiotakos DB, Polychronopoulos E. The role of Mediterranean diet in the epidemiology of metabolic 
syndrome; converting epidemiology to clinical practice. Lipids Health Dis. 2005;4:7.
9. Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, et al. Diet and overall survival in elderly people. BMJ. 
1995;311(7018):1457-1460.
10. Trichopoulou A, Orfanos P, Norat T, et al. Modified Mediterranean diet and survival: EPIC-elderly 
prospective cohort study. BMJ. 2005;330(7498):991.
Chap1_Marieke.indd   15 18-1-2013   15:00:47
General introductionChapter 1
16
1
11. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean 
diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr. 2010;92(5):1189-
1196.
12. Hu FB, Stampfer MJ, Rimm E, et al. Dietary fat and coronary heart disease: a comparison of approaches 
for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol. 
1999;149(6):531-540.
13. White E, Hunt JR, Casso D. Exposure measurement in cohort studies: the challenges of prospective 
data collection. Epidemiol Rev. 1998;20(1):43-56.
14. Erlichman J, Kerbey AL, James WP. Physical activity and its impact on health outcomes. Paper 1: The 
impact of physical activity on cardiovascular disease and all-cause mortality: an historical perspective. 
Obes Rev. 2002;3(4):257-271.
15. Nocon M, Hiemann T, Muller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical 
activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J 
Cardiovasc Prev Rehabil. 2008;15(3):239-246.
16. Li J, Siegrist J. Physical activity and risk of cardiovascular disease-a meta-analysis of prospective cohort 
studies. Int J Environ Res Public Health. 2012;9(2):391-407.
17. Kemper HCG, Ooijendijk WTM, Stiggelbout M. Consensus over de Nederlandse norm voor gezond 
bewegen. Forum. 2000;78:180-183.
18. CBS. StatLine. 2012; http://statline.cbs.nl/statweb/.
19. Haftenberger M, Schuit AJ, Tormo MJ, et al. Physical activity of subjects aged 50-64 years involved 
in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 
2002;5(6B):1163-1176.
20. Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U. Global physical activity levels: 
surveillance progress, pitfalls, and prospects. Lancet. 2012;380(9838):247-257.
21. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical inactivity on major 
non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 
2012;380(9838):219-229.
22. Boone-Heinonen J, Evenson KR, Taber DR, Gordon-Larsen P. Walking for prevention of cardiovascular 
disease in men and women: a systematic review of observational studies. Obes Rev. 2009;10(2):204-
217.
23. Hamer M, Chida Y. Walking and primary prevention: a meta-analysis of prospective cohort studies. 
Br J Sports Med. 2008;42(4):238-243.
24. Zheng H, Orsini N, Amin J, Wolk A, Nguyen VT, Ehrlich F. Quantifying the dose-response of walking 
in reducing coronary heart disease risk: meta-analysis. Eur J Epidemiol. 2009(24):181-192.
25. Oja P, Titze S, Bauman A, et al. Health benefits of cycling: a systematic review. Scand J Med Sci Sports. 
2011;21(4):496-509.
26. Manson JE, Greenland P, LaCroix AZ, et al. Walking compared with vigorous exercise for the prevention 
of cardiovascular events in women. N Engl J Med. 2002;347(10):716-725.
Chap1_Marieke.indd   16 18-1-2013   15:00:47
G
eneral introduction
Chapter 1
17
1
27. Matthews CE, Jurj AL, Shu XO, et al. Influence of exercise, walking, cycling, and overall nonexercise 
physical activity on mortality in Chinese women. Am J Epidemiol. 2007;165(12):1343-1350.
28. Leitzmann MF, Park Y, Blair A, et al. Physical activity recommendations and decreased risk of mortality. 
Arch Intern Med. 2007;167(22):2453-2460.
29. Noda H, Iso H, Toyoshima H, et al. Walking and sports participation and mortality from coronary 
heart disease and stroke. J Am Coll Cardiol. 2005;46(9):1761-1767.
30. Meisinger C, Lowel H, Heier M, Kandler U, Doring A. Association of sports activities in leisure time 
and incident myocardial infarction in middle-aged men and women from the general population: 
the MONICA/KORA Augsburg cohort study. Eur J Cardiovasc Prev Rehabil. 2007;14(6):788-792.
31. Chang ET. The impact of daytime naps on the relation between sleep duration and cardiovascular 
events. Arch Intern Med. 2009;169(7):717.
32. Chandola T, Ferrie JE, Perski A, Akbaraly T, Marmot MG. The effect of short sleep duration on coronary 
heart disease risk is greatest among those with sleep disturbance: a prospective study from the 
Whitehall II cohort. Sleep. 2010;33(6):739-744.
33. Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. 
Expert Rev Cardiovasc Ther. 2008;6(6):883-895.
34. Kenfield SA, Wei EK, Rosner BA, Glynn RJ, Stampfer MJ, Colditz GA. Burden of smoking on cause-
specific mortality: application to the Nurses’ Health Study. Tob Control. 2010;19(3):248-254.
35. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with 
selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.
36. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and time course of decreased risks of 
coronary heart disease in middle-aged women. Arch Intern Med. 1994;154(2):169-175.
37. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in 
women and men: longitudinal population study. BMJ. 1998;316(7137):1043-1047.
38. Woodward M, Lam TH, Barzi F, et al. Smoking, quitting, and the risk of cardiovascular disease among 
women and men in the Asia-Pacific region. Int J Epidemiol. 2005;34(5):1036-1045.
39. Streppel MT, Boshuizen HC, Ocke MC, Kok FJ, Kromhout D. Mortality and life expectancy in relation 
to long-term cigarette, cigar and pipe smoking: the Zutphen Study. Tob Control. 2007;16(2):107-113.
40. Streppel MT, Ocke MC, Boshuizen HC, Kok FJ, Kromhout D. Long-term wine consumption is related to 
cardiovascular mortality and life expectancy independently of moderate alcohol intake: the Zutphen 
Study. J Epidemiol Community Health. 2009;63(7):534-540.
41. Schuit AJ, van Loon AJ, Tijhuis M, Ocke M. Clustering of lifestyle risk factors in a general adult 
population. Prev Med. 2002;35(3):219-224.
42. Poortinga W. The prevalence and clustering of four major lifestyle risk factors in an English adult 
population. Prev Med. 2007;44(2):124-128.
43. Moreno-Gómez C, Romaguera-Bosch D, Tauler-Riera P, et al. Clustering of lifestyle factors in Spanish 
university students: the relationship between smoking, alcohol consumption, physical activity and 
diet quality. Public Health Nutr. 2012;15(11):2131-2139.
Chap1_Marieke.indd   17 18-1-2013   15:00:48
General introductionChapter 1
18
1
44. Ma J, Betts NM, Hampl JS. Clustering of lifestyle behaviors: the relationship between cigarette smoking, 
alcohol consumption, and dietary intake. Am J Health Promot. 2000;15(2):107-117.
45. Lv J, Liu Q, Ren Y, Gong T, Wang S, Li L. Socio-demographic association of multiple modifiable lifestyle 
risk factors and their clustering in a representative urban population of adults: a cross-sectional study 
in Hangzhou, China. Int J Behav Nutr Phys Act. 2011;8:40.
46. Hulshof KF, Wedel M, Lowik MR, et al. Clustering of dietary variables and other lifestyle factors (Dutch 
Nutritional Surveillance System). J Epidemiol Community Health. 1992;46(4):417-424.
47. Chou KL. The prevalence and clustering of four major lifestyle risk factors in Hong Kong Chinese 
older adults. J Aging Health. 2008;20(7):788-803.
48. Odegaard AO, Koh WP, Gross MD, Yuan JM, Pereira MA. Combined lifestyle factors and cardiovascular 
disease mortality in Chinese men and women: the Singapore Chinese health study. Circulation. 
2011;124(25):2847-2854.
49. Kvaavik E, Batty GD, Ursin G, Huxley R, Gale CR. Influence of individual and combined health behaviors 
on total and cause-specific mortality in men and women: the United Kingdom health and lifestyle 
survey. Arch Intern Med. 2010;170(8):711-718.
50. Nechuta SJ, Shu XO, Li HL, et al. Combined impact of lifestyle-related factors on total and cause-specific 
mortality among Chinese women: prospective cohort study. PLoS Med. 2010;7(9). pii: e1000339
51. Ford ES, Zhao G, Tsai J, Li C. Low-risk lifestyle behaviors and all-cause mortality: findings from 
the National Health and Nutrition Examination Survey III Mortality Study. Am J Public Health. 
2011;101(10):1922-1929.
52. van Dam RM, Li T, Spiegelman D, Franco OH, Hu FB. Combined impact of lifestyle factors on mortality: 
prospective cohort study in US women. BMJ. 2008;337:a1440.
53. King DE, Mainous AG, 3rd, Matheson EM, Everett CJ. Impact of healthy lifestyle on mortality in people 
with normal blood pressure, LDL cholesterol, and C-reactive protein. Eur J Cardiovasc Prev Rehabil. 
Sep 30 2011 [Epub ahead of print].
54. Eguchi E, Iso H, Tanabe N, et al. Healthy lifestyle behaviours and cardiovascular mortality among 
Japanese men and women: the Japan collaborative cohort study. Eur Heart J. 2012;33(4):467-477.
55. Knoops KT, de Groot LC, Kromhout D, et al. Mediterranean diet, lifestyle factors, and 10-year mortality 
in elderly European men and women: the HALE project. JAMA. 2004;292(12):1433-1439.
56. Chiuve SE, Fung TT, Rexrode KM, et al. Adherence to a low-risk, healthy lifestyle and risk of sudden 
cardiac death among women. JAMA. 2011;306(1):62-69.
57. Emberson JR, Whincup PH, Morris RW, Wannamethee SG, Shaper AG. Lifestyle and cardiovascular 
disease in middle-aged British men: the effect of adjusting for within-person variation. Eur Heart J. 
2005;26(17):1774-1782.
58. Beulens JW, Monninkhof EM, Verschuren WM, et al. Cohort Profile: The EPIC-NL study. Int J Epidemiol. 
2009;39(5):1170-1178.
59. Verschuren WM, Blokstra A, Picavet HS, Smit HA. Cohort profile: the Doetinchem Cohort Study. Int 
J Epidemiol. 2008;37(6):1236-1241.
Chap1_Marieke.indd   18 18-1-2013   15:00:48
PLoS One. 
2012;7(9):e45458.
Mediterranean style diet 
and 12-year incidence of 
cardiovascular diseases. 
the ePIc-nl cohort study
Marieke P. Hoevenaar-Blom, Astrid C.J. Nooyens, 
Daan Kromhout, Annemieke M.W. Spijkerman, 
Joline W.J. Beulens, Yvonne T. van der Schouw, 
Bas Bueno-de-Mesquita, W.M. Monique Verschuren
chapter 2
Chap2_Marieke.indd   19 18-1-2013   15:00:54
Mediterranean style diet and cardiovascular diseasesChapter 2
20
2
AbstrAct 
Background: A recent meta-analysis showed that a Mediterranean style diet may protect 
against cardiovascular diseases (CVD). Studies on disease-specific associations are limited. 
We evaluated the Mediterranean Diet Score (MDS) in relation to incidence of total and 
specific CVDs. 
Methods: The EPIC-NL Study is a cohort of 40,011 men and women aged 20–70 years, 
examined between 1993 and 1997, with 10–15 years of follow-up. Diet was assessed with 
a validated food frequency questionnaire and the MDS was based on the daily intakes 
of vegetables, fruits, legumes and nuts, grains, fish, fatty acids, meat, dairy, and alcohol. 
Cardiovascular morbidity and mortality were ascertained through linkage with national 
registries. Cox proportional hazards models were used to estimate hazard ratios (HRs) 
and 95% confidence intervals (CI) adjusted for age, sex, cohort, smoking, physical activity, 
total energy intake, and educational level. 
Results: In 34,708 participants free of CVD at baseline, 4,881 CVD events occurred, and 
487 persons died from CVD. A two unit increment in MDS (range: 0–9) was inversely 
associated with fatal CVD (HR: 0.78; 95% CI: 0.69–0.88), total CVD (HR: 0.95 [0.91–0.98]), 
myocardial infarction (HR: 0.86 [0.79–0.93]), stroke (HR: 0.88 [0.78–1.00]), and pulmonary 
embolism (HR: 0.74 [0.59–0.92]). The MDS was not related to incident angina pectoris, 
transient ischemic attack and peripheral arterial disease. 
Conclusion: Better adherence to a Mediterranean style diet was more strongly associated 
with fatal CVD than with total CVD. Disease specific associations were strongest for incident 
myocardial infarction, stroke and pulmonary embolism. 
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IntroductIon 
For a long time, the focus of nutritional research was on nutrients. However, interactions, synergy 
and correlations among nutrients will influence their bioavailability and absorption.1,2 Therefore, 
investigating the relation of single nutrients with cardiovascular diseases (CVD) is not sufficient, 
and also individual foods and food patterns need to be studied in relation to CVD incidence.
The traditional Mediterranean diet is a prototype of a healthy diet and is associated with a low risk 
of CVD.3 Key features of a traditional Mediterranean diet are the use of olive oil as the principal 
component of fat; relatively high consumption of fruit, vegetables, fish, whole grains, legumes, 
and nuts; low consumption of meat and dairy; and moderate alcohol consumption with meals.4,5 
Controlled trials showed that a Mediterranean style diet was associated with favorable changes 
in body weight, body mass index, systolic and diastolic blood pressure, fasting plasma glucose, 
total cholesterol and high-sensitivity C-reactive protein, which may all affect CVD incidence.6 
In a secondary prevention trial in myocardial infarction patients, a Mediterranean style diet 
enriched with alpha-linolenic acid was associated with a 73% lower risk of cardiac death and 
non-fatal myocardial infarction compared with a prudent diet.7,8 Also, in a cohort study on 
the Mediterranean diet and survival among Greek cardiac patients, a higher adherence to the 
Mediterranean diet was strongly inversely associated with cardiac death.9
A recent meta-analysis showed that each two unit increment in the MDS was associated with 
a 10% lower incidence of CVD.10 The meta-analysis combined studies with different fatal and 
nonfatal CVD enpoints.10 The recently published prospective cohort study by Gardener et al. 
observed an association of the MDS with fatal CVD, but not with incident myocardial infarction 
or ischemic stroke.11 These results suggest that a Mediterranean style diet may affect the risk of 
specific CVD differently. Gardener et al. concluded that studies on Mediterranean style diets in 
relation to specific CVD endpoints are needed.11 Associations of Mediterranean style diets with 
angina pectoris, transient ischemic attack, peripheral arterial disease, or pulmonary embolism 
have not yet been investigated. 
The purpose of the present study was to investigate a Mediterranean style diet, as a prototype 
of a healthy diet, in association with incident fatal CVD, total CVD, and with specific CVD. The 
secondary aim was to explore which of the components of the MDS contributed most to these 
associations by assessing the effect of alternately excluding components of the MDS.
Methods
study population
The EPIC-NL cohort is the Dutch contribution to the European Prospective Investigation into 
Cancer and Nutrition (EPIC) and consists of the Monitoring Project on Risk Factors for Chronic 
Chap2_Marieke.indd   21 18-1-2013   15:00:54
Mediterranean style diet and cardiovascular diseasesChapter 2
22
2
Diseases (MORGEN) and the PROSPECT cohort. Baseline data of the 40,011 participants were 
collected between 1993 and 1997. The MORGEN cohort consists of 22,654 men and women 
aged 20–65 years who were recruited through random population sampling in three Dutch 
towns (Amsterdam, Maastricht and Doetinchem).12 The PROSPECT cohort included 17,357 
women aged 50–70 years, who participated in a breast cancer screening program in the 
province of Utrecht. 
We excluded participants with prevalent CVD or type 2 diabetes based on self-report and 
hospital admission data (n=1,401), women who were pregnant at baseline (n=140), those with 
extremely low or high reported energy intakes (i.e., those in the lowest and highest 0.5% of the 
ratio of energy intake over basal metabolic rate) (n=373), those with no information on dietary 
intake or any of the covariates (n=855), as well as those with no information on vital status or 
cardiovascular events (n=2,534). In total 34,708 participants remained for the analyses. 
ethics statement
All participants signed an informed consent form prior to study inclusion. The study complies 
with the Declaration of Helsinki and was approved by two medical ethics committees.12
Mediterranean style diet
Dietary intake was assessed by a validated13,14 food frequency questionnaire (FFQ) which 
contained questions on the habitual frequency of consumption of 178 food items during the 
year preceding enrollment. Additional information was obtained on consumption frequency 
for different sub-items, and preparation methods. Colored photographs were used to estimate 
portion sizes of 28 food items.13,14 Reproducibility and validity were assessed in 121 men and 
women.13,14 Median twelve-month reproducibility of 16 food groups was 0.71 for men and 0.77 
for women, ranging from resp. 0.45 and 0.63 for fish to 0.83 and 0.92 for alcoholic beverages.13 
The median validity of these 16 food groups, with 12 monthly 24-hour recalls as reference, was 
0.61 for men and 0.53 for women, ranging from 0.32 for fish in men and 0.31 for vegetables in 
women to 0.74 (men) and 0.87 (women) for alcoholic beverages.13 
We operationalized the concept of a healthy diet with the modified Mediterranean Diet Score 
(MDS) defined by Trichopoulou et al.5 For the composition of this score, values of 0 or 1 were 
assigned to each nutritional component using the sex-specific medians as cut-off values. For 
vegetables, fruits, legumes and nuts combined, grains, fish and seafood combined, and the ratio 
of unsaturated to saturated fatty acids, intakes equal to or above the median were assigned 
a value of 1, and for intakes below that median a value of 0. For meat and for dairy products 
the scoring was inverted. We dichotomized alcohol consumption into non-users and users, 
because of the relatively low levels of alcohol consumption in this population. We did not define 
an upper limit for alcohol consumption, due to the low levels of alcohol consumption in the 
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present population, and called the alcohol consumption of our population moderate. A value 
of 1 was assigned for consuming at least one drink per month and a value of 0 for consuming 
less than 1 drink per month. The modified MDS could take a value from 0 (minimal adherence) 
to 9 (maximal adherence)5 and associations with CVD were assessed in categories 0–2, 3–4, 5–6 
and 7–9 and by two unit increment.
Ascertainment of fatal and nonfatal cVd events
Participants were followed to the first nonfatal cardiovascular event, death, emigration, or were 
censored at January 1st 2008. Morbidity data were provided by the National Medical Registry 
(NMR) using the Dutch Hospital Discharge data. Eighty-eight percent of the hospital admissions 
could uniquely be linked to an individual on the basis of sex, date of birth, and postal code.15 
In a validation study conducted in a subsample of this population, the Hospital Discharge data 
was compared with that of a detailed clinical registry.16 A sensitivity of 84% was observed for 
acute myocardial infarction hospital admissions.16 We obtained vital status through linkage 
with municipal population registries. Subsequently, primary (underlying) and secondary causes 
of death were obtained through linkage with data from ‘Statistics Netherlands’.12 In a study 
in which causes of death were coded again two years after initial coding, agreement ranged 
from 77–89% for CVD.17 
Incidence was defined as both fatal and nonfatal events unless otherwise specified. For fatal 
and nonfatal incidence combined, only first events were taken into account. For instance, when 
a person experienced a myocardial infarction followed by a pulmonary embolism, this person 
was censored after the myocardial infarction. For fatal CVD, no exclusions were made due to 
previous nonfatal events during follow-up. Total CVD was coded as ICD918 codes 390–459 and 
798. Myocardial infarction was coded as 410–412 and 414, angina pectoris as 413, stroke as 
430–434, and 436, transient ischemic attack as 435, peripheral arterial disease as 440–444, and 
pulmonary embolism as 415.1. The remaining CVD codes were coded as other CVD. Composite 
CVD consisted of fatal CVD, plus nonfatal first myocardial infarction and stroke. Causes of death 
after 1996 were coded according to the corresponding ICD1019 codes.
covariates
A self-administered general questionnaire provided information on educational level, smoking 
status, and physical activity.12 Educational level was operationalized as low (lower vocational 
training or primary school), medium (secondary school and intermediate vocational training), 
or high (higher vocational training or university) and cigarette, cigar or pipe smoking as current, 
former or never. Physical activity was assessed using the validated20 EPIC questionnaire and 
dichotomized according to the Cambridge Physical Activity Index (CPAI) into (moderately) 
active and (moderately) inactive.21 In the first year of the MORGEN study (1993, 14.2% of the 
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study population), physical activity was not assessed with the EPIC questionnaire. The missing 
physical activity data were imputed using single imputation as previously described (SPSS MVA 
procedure).22 
statistical analysis
Statistical analyses were performed using SAS 9.2 software (SAS Institute, INC., Cary, NC). 
Participants’ characteristics were calculated by sex and cohort as means (standard deviation) 
or medians (inter-quartile range) for continuous variables, and as percentages for categorical 
variables. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% 
confidence intervals (CI). The proportional hazard assumption was fulfilled according to the 
graphical approach and according to Schoenfeld residuals. Two consecutive models were used to 
assess the associations between the MDS and the CVD endpoints. The first model was adjusted 
for age, sex and cohort. The second model was additionally adjusted for smoking, physical 
activity, total energy intake, and educational level. We did not include BMI, blood pressure or 
serum cholesterol in our analyses, since we consider these intermediates in the association 
between a Mediterranean style diet and CVD. By adding interaction terms to the models, we 
assessed interaction on a multiplicative scale for age, sex, and cohort in the association between 
the MDS and the different cardiovascular endpoints. We also explored which of the components 
of the MDS contributed most to the associations for those CVD that were related to the MDS 
at p<0.10. For this, we alternately excluded one component of the MDS while adjusting for 
the excluded component. This reduced the ten point score (0–9) to a nine point score (0–8). 
To preserve comparability between the ten point and the nine point scores, we multiplied the 
logarithm of the estimated nine mortality ratios by 9/10 before exponentiating them.23
To minimize the possibility that dietary habits had changed in response to development of 
intermediate symptoms (e.g. hypertension) during follow-up (reversed causation), the analyses 
were repeated after exclusion of persons with an event in the first two years of follow-up.
results
During 10–15 years of follow-up (mean 11.8 years) 4,881 CVD events occurred, and 487 persons 
died from CVD. table 2.1 shows the distribution of participants’ characteristics and dietary 
intake stratified by sex and cohort. 25% of the population was male. Mean age at baseline 
was 43 years for men, 42 years for women in MORGEN and 58 years for women in PROSPECT. 
Dietary intake was similar in women in MORGEN and PROSPECT, with the exception of fruit 
consumption, which was higher in PROSPECT. 
After adjustment for all confounders, each two unit increment in MDS was associated with a 
22% lower incidence of fatal CVD (HR: 0.78; 95% CI: 0.69–0.88), a 5% lower incidence of total 
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CVD (HR: 0.95 [0.91–0.98]), and a 15% lower incidence of composite CVD (HR: 0.85 [0.80–0.91]) 
(table 2.2). For specific CVD, statistically significant associations were observed for incident 
myocardial infarction (HR: 0.86 [0.79–0.93]), stroke (HR: 0.88 [0.78–1.00]), and pulmonary 
embolism (HR: 0.74 [0.59–0.92]). The strength of the association of the MDS with ischemic 
(HR: 0.86 [0.72–1.01]) did not differ from that with hemorrhagic stroke (0.87 [0.60–1.09]). The 
table 2.1 Participants’ characteristics at baseline and cVd incidence, by sex and cohort, the ePIc-
nl study
 Men (MORGEN) Women (MORGEN) Women (PROSPECT)
n 8,764 10,537 15,407
Age (years) a 43 (11) 42 (11) 58 (6)
Education (% low)b 32 35 45
Smoking (%)c 38 35 23
Physically active (%) 71 68 67
Alcohol consumption (%, ≥1 
glass per month)
91 77 78
Alcohol (gram/day)a 12 (3–25) 3 (0–11) 4 (1–13)
Energy intake (kcal/day) a 2,518 (2,139–2,987) 1,932 (1,635–2,265) 1,763 (1,508–2,046)
Vegetables (gram/day)a 103 (77–134) 113 (86–147) 123 (95–158)
Fruit (gram/day)a 117 (51–186) 124 (78–239) 224 (119–295)
Legumes (gram/day)a 15 (8–24) 12 (6–20) 12 (6–20)
Nuts (gram/day)a 7 (2–16) 4 (2–10) 4 (1–8)
Grains (gram/day)a 250 (188–319) 184 (142–234) 147 (115–184)
Fish and seafood (gram/day)a 8 (3–14) 7 (3–14) 8 (3–16)
Unsaturated fatty acids (gram/
day)a 
58 (47–71) 44 (36–54) 36 (29–44)
Saturated fatty acids (gram/day)a 41 (33–50) 32 (25–39) 28 (22–34)
Dairy and dairy products (gram/
day)a 
353 (196–578) 346 (196–548) 414 (267–597)
Meat products (gram/day)a 141 (105–179) 102 (63–131) 87 (54–118)
Fatal CVD (n/%)d 136/1.6 70/0.7 281/1.8
Incident CVD (n/%)d 1,202/13.7 1,078/10.2 2,601/16.9
Composite CVD (n/%)d,e 548/6.3 317/3.0 900/5.8
Incident MI (n/%)d 390/4.5 184/1.8 496/3.2
Incident AP (n/%)d 116/1.3 70/0.7 193/1.3
Incident stroke (n/%)d 93/1.1 95/0.9 260/1.7
Incident TIA (n/%)d 32/0.4 32/0.3 90/0.6
Incident PAD (n/%)d 102/1.2 48/0.5 135/0.9
Incident PE (n/%)d 25/0.3 35/0.3 71/0.5
Incident other CVD (n/%)d 450/5.1 621/5.9 1,376/8.9
CVD, cardiovascular diseases; MI, myocardial infarction; AP, angina pectoris; TIA, transient ischemic attack; 
PAD, peripheral arterial disease; PE, pulmonary embolism.
a Numbers are given as mean (sd) or as median (interquartile range); b Low educational level: lower vocational 
training or primary school; c Cigarette, cigar or pipe; d See method section for ICD codes; e Composite of 
fatal CVD, nonfatal myocardial infarction and nonfatal stroke.
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association with pulmonary embolism was not linear: the largest decrease in HR was between 
the MDS categories ‘0–2’ and ‘3–4’. Also, the association with pulmonary embolism was stronger 
for men (HR: 0.39 [0.23–0.67] per two unit increment) than for women (HR 0.84 [0.65–1.07]) 
(p for interaction: <0.01). Adherence to a Mediterranean style diet was not related to incident 
angina pectoris, transient ischemic attack and peripheral arterial disease. We observed no other 
interactions with age, sex (except for pulmonary embolism) or cohort. Exclusion of cases in the 
first two years of follow-up hardly changed our results (data not shown).
In general, alternately excluding one of the components of the MDS did not materially change 
our results (table 2.3). The exclusion of alcohol from the MDS had the largest impact on the 
associations of MDS with CVD, in particular for incident fatal CVD, total CVD, composite CVD 
and myocardial infarction. Excluding fish and seafood or the fatty acid ratio attenuated the 
association for pulmonary embolism most.
dIscussIon
This study showed that a Mediterranean style diet was inversely associated with total CVD and 
more strongly so with fatal CVD. Inverse associations were also observed for composite CVD, 
myocardial infarction, stroke and pulmonary embolism. The MDS was not related to incident 
angina pectoris, transient ischemic attack and peripheral arterial disease. Alternate exclusion 
of components of the MDS showed that alcohol contributed most to the inverse association 
between MDS and CVD. 
In the present study, a MDS of 7–9 was associated with a 56% lower incidence of fatal CVD 
compared to a MDS of 0–2, with a 16% lower incidence of total CVD and a 35% lower incidence 
of composite CVD. Comparison of our results with those of other investigations is hampered 
by differences in definition of Mediterranean style diet and of CVD endpoints. In previous 
studies, the MDS varied in definition of the components. Also, adherence to a Mediterranean 
style diet was categorized in various ways, ranging from two, to five categories of adherence.10 
The definition of CVD also varied among studies, with various combinations of ICD codes and 
inclusion of fatal or nonfatal CVD events. Taken together, results of previous studies showed 
that high compared to low adherence to a Mediterranean style diet was associated with a 2024 
to 40%25,26 lower incidence of fatal CVD and a 2025 to 25%11 lower incidence of composite CVD. 
These results are in line with those in the present study. 
The association of the MDS with fatal CVD was stronger than with total CVD. A stronger 
association with fatal CVD may be due to the probabilistic linkage of the non-fatal Hospital 
Discharge data causing more misclassification than for fatal events. This may have resulted in 
weaker associations for nonfatal CVD. Furthermore, our results showed that adding ‘softer’ 
endpoints such as transient ischemic attack, angina pectoris and peripheral arterial disease 
to the composite of ‘hard’ endpoints reduced the strength of the associations considerably. 
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Therefore, in discussing the strength of associations with different CVD endpoints, the definition 
of the latter is of utmost importance.
For the highest compared to the lowest MDS category we observed a 30% lower incidence of 
myocardial infarction and for each two unit increment a 14% lower incidence. This was in line 
with a recent cohort study in 2,568 men and women in the United States by Gardener et al. who 
observed a 39% lower incidence of myocardial infarction for the highest compared to the lowest 
MDS category, and for each 1 unit increment a 6% lower incidence, though these associations 
were non-significant due to the small sample size.11 Our results are also consistent with those 
observed in other cohort studies, in which high compared to low adherence to a Mediterranean 
style diet was associated with a 30–40% lower incidence of coronary heart disease,25-29 although 
coronary heart disease incidence was defined differently in the various studies.
The inverse association between the MDS and stroke incidence in the present study (highest 
compared to lowest category HR: 0.70 [0.47–1.05] and for a two unit increment HR: 0.88 
[0.78–1.00]) is in agreement with the results Fung et al. obtained in the Nurses Health Study.25 
They observed a 13% lower incidence of stroke for those in the highest compared to the 
lowest quintile of adherence to a Mediterranean style diet.25 The results of the cohort studies 
published so far, including ours (results not shown), showed similar results for ischemic and 
hemorrhagic stroke.11,25
We observed that the MDS was inversely associated with the incidence of pulmonary embolism. 
This association was stronger for men than for women. Diet is hypothesized to affect venous 
thromboembolism, and thereby pulmonary embolism, by altering levels of haemostatic and 
fibrinolytic factors.30 To our knowledge other studies did not investigate diet in relation to 
pulmonary embolism before. However, we could compare our results with those of three large 
cohort studies investigating the relation of diet with venous thromboembolism. The results 
of these studies were inconsistent.31-33 Therefore, our results for pulmonary embolism need 
confirmation by other prospective cohort studies. 
In the present study, the MDS was not statistically significantly related to incident angina 
pectoris, transient ischemic attack and peripheral arterial disease. To our knowledge these 
associations have not been investigated earlier. These three diseases are ‘softer’ endpoints than 
e.g. myocardial infarction and stroke. This may have resulted in more misclassification16 which 
may have diluted the associations of the MDS with these endpoints. 
The associations of the MDS with fatal CVD, incident CVD, composite CVD, and myocardial 
infarction attenuated most when excluding alcohol from the MDS. Excluding fish and seafood 
or the fatty acid ratio attenuated the association with pulmonary embolism most. No previous 
study on the MDS in relation to CVD assessed the effect of alternately excluding components 
of the MDS. Trichopoulou et al. observed for the association between MDS and all-cause 
mortality also most attenuation after excluding alcohol consumption from the MDS.23 Previous 
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studies on a Mediterranean style diet assessing the contribution of its individual components 
to CVD incidence showed inconsistent results with respect to which component was strongest 
associated to CVD.11,27,29 
We studied the adherence to a Mediterranean style diet in a Dutch population. The Dutch diet 
is characterized by a low consumption of plant foods and fish and by a high consumption of 
animal foods compared to the traditional Mediterranean diet.34 However, similar associations of 
a Mediterranean style diet with CVD were observed in Mediterranean, Northern European and in 
American populations.10 This implies that, at different levels of adherence, a Mediterranean style 
diet is beneficial in relation to cardiovascular health. Furthermore, our associations were robust 
since in sensitivity analyses, including only whole grain cereals in the component ‘cereals’, or 
only moderate to high fat meat products and dairy products in the components ‘meat products’ 
and ‘dairy products’, hardly changed the results (results not shown). Also additionally adjusting 
the components of the MDS for energy intake (density method) or exclusion of cases in the 
first two years of follow-up hardly changed our results (results not shown).
Some limitations of our study need to be addressed. Dietary intake was self-reported using a 
validated food-frequency questionnaire (FFQ). This questionnaire had a good reproducibility, 
although the validity of vegetable (Spearman correlation coefficients: 0.38 for men and 0.31 for 
women) and fish (0.32 for men and 0.37 for women) consumption is of concern.13,14 In addition, 
diet was assessed only once and may have changed during follow-up, resulting in non-differential 
misclassification that may have attenuated the observed associations. Furthermore, our study is 
a prospective cohort study in which adherence to MDS was not randomized. Therefore, residual 
confounding cannot be ruled out. With regard to the cardiocascular follow-up, ‘hard’ endpoints, 
like myocardial infarction or stroke, are easier to diagnose than ‘softer’ endpoints like angina 
pectoris, transient ischemic attack or peripheral arterial disease. Also, ‘hard’ endpoints are 
more likely to be treated in the hospital than ‘softer’ ones, and thus monitored in the Hospital 
Discharge Registries.16 In a validation study comparing the Hospital Discharge data to that of a 
cardiology information system, sensitivity was considerably larger for acute myocardial infarction 
(84%) than for unstable angina pectoris (53%).16 Therefore, misclassification is likely smaller for 
the ‘hard’ events, which may have resulted in stronger associations. 
The present study also has advantages. EPIC-NL is a large prospective cohort study, especially 
designed to study associations between diet and chronic diseases, and included both men 
and women from the general population, with a broad age range and a long follow-up period. 
Because of the detailed cardiovascular follow-up data and the large sample size, we were able 
to investigate associations of a Mediterranean style diet with specific CVD.
In conclusion, the present study showed that better adherence to a Mediterranean style diet 
was more strongly associated with fatal CVD than with total CVD. Disease specific associations 
were strongest for incident myocardial infarction, stroke and pulmonary embolism.
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AbstrAct 
Background: In cohort studies, often only the baseline measurement of dietary intake 
is available. This may underestimate the strength of the association with cardiovascular 
diseases (CVD). 
Objective: To compare the strength of the association of a Mediterranean style diet with 
CVD using the baseline measurement of diet versus three repeated measurements over 
a 10-year period. 
Design: We used dietary and lifestyle data of three rounds of the Doetinchem Cohort 
Study. Diet was assessed with a 178 item validated food frequency questionnaire 
and operationalized with the Mediterranean Diet Score (MDS) ranging from 0–9. Cox 
proportional hazards models were used to estimate hazard ratios (HRs) and 95% 
confidence intervals (CI), for baseline MDS and updated mean MDS in association with fatal 
CVD and a composite of fatal CVD, non-fatal myocardial infarction and stroke. All analyses 
were adjusted for age, sex, smoking, sports, total energy intake, and educational level. 
Results: 206 composite CVD events occurred, of which 38 were fatal. Baseline MDS was 
associated with a 23% lower risk (HR: 0.77 [95% CI: 0.53–1.11]) and the updated mean with 
a 35% lower risk (HR: 0.65 [0.43–0.97]) of composite CVD, for an MDS of 5.5–9 compared 
to an MDS of 0–3.5. For fatal CVD, baseline MDS was associated with a 13% lower risk 
(HR: 0.87 [0.36–2.07]) and the updated mean with a 56% lower risk (HR: 0.44 [0.19–1.05]). 
Conclusion: The strength of the association between a Mediterranean style diet and CVD 
incidence is likely underestimated because most studies so far used only the baseline 
measurement. 
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IntroductIon 
In many cohort studies, often only the baseline measurement of dietary intake is available 
to estimate the strength of the association of dietary patterns with cardiovascular diseases 
(CVD). Using only the baseline measurements may underestimate the true association of a 
dietary pattern with CVD. Multiple measurements of dietary intake over a longer period could 
strengthen the observed associations for two reasons. Firstly, averaging multiple measurements 
reduces random measurement error.1,2 Secondly, multiple measurements over a longer period 
of time better represent long-term dietary intake since they take changes in dietary intake 
into account.1 
Several studies investigated the effect of repeated measurements of single foods or nutrients 
on the strength of associations.1,3-5 However, to the best of our knowledge, no previous study 
investigated the effect of measuring dietary patterns multiple times on the strength of the 
association with CVD. Two studies of the Nurses Health cohort used multiple measurements to 
estimate long-term dietary patterns in relation to breast cancer6 and (cause specific) mortality7. 
In a sensitivity analysis they observed ‘similar associations’6 or ‘similar but weaker associations’7 
for baseline measurements compared to multiple measurements of dietary patterns, though 
the strength of these associations was not reported. Also in a study on fish consumption in 
relation to major chronic diseases in the Health Professionals Follow Up cohort ‘no appreciable 
difference’ was reported between baseline intake only and five measurements of fish intake 
over 16 years based on a sensitivity analysis.3 Three studies on nutrients and foods dealt with 
the issue of multiple measurements versus the baseline measurement.1,4,5 One study was on 
alcohol consumption in relation to all cause mortality and coronary heart disease, one on 
tomato products and lycopene in relation to prostate cancer, and one on dietary fat and 
coronary heart disease.1,4,5 These studies generally observed stronger associations for multiple 
measurements than for the baseline measurement only.1,4,5 Overall, the studies carried out so 
far suggest that the effect of multiple measurements was stronger for nutrients than for foods 
and dietary patterns.
Besides improvements in dietary exposure measurement, also covariates may be better classified 
with multiple measurements. Though Hu et al. noted that the use of baseline or updated 
covariates yielded similar results in a study on dietary fat and coronary heart disease,1 for some 
covariates recent exposure may be etiologically more relevant than baseline exposure, because 
effects are expected on the short-term instead of on the long-term. For example, Kenfield 
et al. noted that associations of former and current smoking with cardiovascular mortality 
were stronger when updated information was used.8 Therefore, adjustment for smoking may 
improve when updated information is used. Assuming that associations are attenuated after 
better adjustment for confounders, we hypothesized that adjustment for recent confounders 
would result in weaker effect estimates for the associations between dietary patterns 
and CVD. 
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This paper describes the association of the Mediterranean Diet Score (MDS) with fatal CVD 
and a composite of fatal CVD, non-fatal myocardial infarction and stroke, comparing only the 
baseline measurement of the diet with three repeated measurements. In addition, we explored 
the impact of adjustment for most recent measurements of confounders compared to adjustment 
for the baseline measurement of confounders only.
subJEcts And MEtHods
study population
The Doetinchem Cohort Study is a longitudinal cohort study of a general population sample 
from the town of Doetinchem, located in a rural area in the eastern part of the Netherlands. 
Ethical approval for this study was obtained from the Medical Ethics Committee TNO, Zeist, 
the Netherlands. During the first examination round (1987–1991) 12,405 men and women 
aged 20 to 59 years were examined. For the second round (1993–1997), a random two-third 
of those who were measured in the first round were re-invited. For the third (1998–2002) and 
fourth (2003–2007) round, all persons who participated in the second round were re-invited, 
excluding those who emigrated, actively withdrew from the study or had died. As of the second 
round, a validated9,10 food-frequency questionnaire was used. Therefore, these data were used 
as baseline for the present study. The response rates for the measurement rounds ranged from 
75% to 79%. More details of the Doetinchem Cohort Study are described elsewhere.11
To compare results of the baseline MDS with those of repeated measurements, we excluded 
persons who did not participate in all measurement rounds before censoring or getting an 
event. Furthermore, we excluded participants with prevalent CVD or type 2 diabetes, women 
who were pregnant, those with extremely low or high reported energy intakes (i.e., those in 
the lowest and highest 0.5% of the ratio of energy intake over estimated basal metabolic rate), 
people reporting to be on a diet prescribed by a doctor or a dietician, those with no information 
on dietary intake or any of the covariates, as well as those with no information on vital status 
or cardiovascular events. A total of 3,417 persons remained for the analyses on composite CVD 
and 3,357 persons for the analyses on fatal CVD.
Mediterranean diet score
Dietary intake was assessed by a validated9,10 food frequency questionnaire (FFQ) which contained 
questions on the habitual frequency of consumption of 178 food items during the year preceding 
enrollment. Additional information was obtained on consumption frequency for different sub-
items, and preparation methods. Colored photographs were used to estimate portion sizes of 28 
food items.9,10 Reproducibility and validity were assessed in 121 men and women.9,10 The median 
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12-months reproducibility (Spearman correlation coefficients) of 16 food groups was 0.71 for 
men and 0.77 for women, ranging from resp. 0.45 and 0.63 for fish to 0.83 and 0.92 for alcoholic 
beverages.10 In a validation study with 12 monthly 24-hour recalls, the median relative validity 
of these 16 food groups was 0.61 for men and 0.53 for women, ranging from 0.32 for fish in men 
and 0.31 for vegetables in women to 0.74 (men) and 0.87 (women) for alcoholic beverages.10
We operationalized the concept of a healthy diet with the modified Mediterranean Diet Score 
(MDS) defined by Trichopoulou et al.12 For the composition of this score, values of 0 or 1 were 
assigned to each nutritional component of the MDS using sex-specific medians. We used 
the median intakes at baseline as cut-off values for all subsequent measurement rounds. For 
vegetables, fruits, legumes & nuts, grains, fish & seafood, and the ratio of unsaturated to 
saturated fatty acids, intakes equal to or above the baseline median were assigned a value 1, 
and intakes below the median a value 0. As the traditional Mediterranean diet is characterized 
by a low intake of meat and dairy products, the scoring of these products was inverted. We 
dichotomized alcohol consumption into consumers and non-consumers, because of the relatively 
low level of alcohol consumption in this population. At baseline, 22% consumed more than 
two glasses of alcohol per day. A value of 1 was assigned for consuming at least one drink per 
month (users) and a value of 0 for consuming less than 1 drink per month (non-users). The MDS 
could take a value from 0 (minimal adherence) to 9 (maximal adherence)12 and associations 
with CVD were assessed for the categories 0–3.5, >3.5–5.5, and >5.5–9.
Ascertainment of fatal and nonfatal cVd events
Participants were followed to the first nonfatal cardiovascular event, death, emigration, or were 
censored at January 1st 2008. Morbidity data were provided by the National Medical Register 
(NMR) using the Dutch Hospital Discharge data. Eighty-eight percent of the hospital admissions 
can uniquely be linked to an individual on the basis of sex, date of birth, and postal code.13 
We obtained vital status through linkage with municipal population registers. Subsequently, 
primary and secondary causes of death were obtained through linkage with data from ‘Statistics 
Netherlands’.14 
Composite CVD was defined as fatal CVD (ICD915 codes 390–459 and 798), plus nonfatal 
myocardial infarction (410–412 and 414) and stroke (430–434, and 436). Causes of death after 
1996 were coded according to the corresponding ICD1016 codes. For nonfatal myocardial 
infarction and stroke, only first events were taken into account. For fatal CVD, no exclusions 
were made because of previous nonfatal events. 
covariates
A self-administered general questionnaire provided information on age, sex, educational level, 
smoking status, and sports participation.14 Educational level was operationalized as low (lower 
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vocational training or primary school), medium (secondary school and intermediate vocational 
training), or high (higher vocational training or university). Current cigarette smoking and sports 
participation (≥4 MET) were operationalized as yes or no. 
statistical analyses
Statistical analyses were performed using SAS 9.3 software (SAS Institute, INC., Cary, NC). Parti-
cipants’ characteristics were presented by measurement round as means (standard deviation) or 
medians (inter-quartile range) for continuous variables, and as percentages for categorical variables. 
Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence 
intervals (CI) for the relation of baseline MDS and the updated mean of the MDS with composite 
and fatal CVD incidence using all measurement rounds preceding the event or censoring. The 
proportional hazard assumption for baseline MDS in relation to composite and fatal CVD 
was fulfilled according to the graphical approach and according to Schoenfeld residuals. To 
calculate updated means of the MDS and of total energy intake, we calculated the means of 
these variables at the time of each consecutive measurement round from baseline until the first 
event or censoring.1 The associations between the MDS and the CVD endpoints were adjusted 
for age, and sex. In the second model associations were additionally adjusted for baseline 
smoking, sports, total energy intake, and educational level. In the third model associations 
were additionally adjusted for the most recent levels of the same non-dietary covariates and 
the updated mean of total energy intake. To adjust for the most recent smoking (yes, no) and 
sports participation (yes, no) data we updated the information at each measurement round.1 
We did not include BMI, blood pressure or serum cholesterol in our analyses, since we consider 
these to be intermediates in the association between a Mediterranean style diet and CVD.
rEsults
table 3.1 shows the distribution of the participants’ characteristics by measurement round. 
Participants were on average 45 years old at baseline, and 49% were men. At baseline, 
27% of the participants were current smokers, which decreased to 20% after 10 years. At 
all measurement rounds, more than half of the participants performed sports. Total energy 
intake decreased from 2,200 kcal per day at baseline to 2,050 kcal per day after 10 years. 
Especially the consumption of grains, dairy, and meat products was lower at later rounds than 
at baseline. Median fruit consumption increased over 10 years from 125 to 172 grams per day 
and median fish consumption from 8 to 13 grams per day. Although median MDS was 5 at all 
three measurement rounds, 55% of the participants showed a change of at least 2 MDS points 
between two subsequent rounds. The Spearman correlation coefficients were 0.47 for MDS at 
baseline and five years later, and 0.39 for MDS at baseline and ten years later.
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During 10–15 years of follow-up (mean 12 years) 206 composite CVD events occurred, of which 
38 were fatal. In table 3.2 the results for MDS in relation to CVD are shown, using baseline 
confounders for the model with baseline MDS and the most recent confounders for the model 
with the updated mean of the MDS. Since the associations were not linear, we describe the 
regression coefficients of the MDS-category of 5.5–9 compared to 0–3.5. Baseline MDS was 
associated with a 23% lower risk (HR: 0.77 [0.53–1.11]) of composite CVD and the updated 
mean with a 35% lower risk (HR: 0.65 [0.43–0.97]). For fatal CVD, baseline MDS was associated 
with a 13% lower risk (HR: 0.87 [0.36–2.07]) and the updated mean with a 56% lower risk (HR: 
0.44 [0.19–1.05]). 
table 3.3 shows the influence of different ways to adjust the associations between the updated 
mean MDS and CVD for confounders. Compared to a model with only age and sex as covariates, 
additional adjustment for smoking, sports, energy intake and educational level resulted in 
weaker associations. Adjustment for the most recent levels of the confounders resulted in a 
table 3.1 Population characteristics doetinchem cohort study, by measurement round
 
 
Round 2
1993–1997
Round 3
1998–2002
Round 4
2003–2007
n 3,417 3,353 3,328
Age (y)a 45 (10) 50 (10) 55 (10)
Sex (% men) 49 49 49
Education (% low)b 51 48 47
Current smokers (%) 27 24 20
Alcohol users (%) 86 86 84
Sports participation (% yes) 54 55 58
Energy intake (kcal/day) 2,202 (1,863–2,629) 2,137 (1,820–2,543) 2,053 (1,745–2,411)
Mediterranean Diet Scorea 5 (4–6) 5 (4–6) 5 (4–6)
Mds components
Vegetables (gram/day)a 107 (83–134) 106 (83–135) 105 (81–134)
Fruit (gram/day)a 125 (85–242) 126 (81–243) 172 (89–247)
Legumes (gram/day)a 14 (8–23) 14 (7–21) 12 (6–20)
Nuts (gram/day)a 7 (2–14) 7 (3–15) 7 (2–15)
Grains (gram/day)a 210 (161–263) 205 (158–262) 197 (155–251)
Fish and seafood (gram/day)a 8 (3–14) 9 (4–16) 13 (7–18)
Dairy and dairy products (gram/day)a 418 (267–605) 395 (258–586) 366 (230–552)
Meat and meat products (gram/day)a 118 (84–149) 113 (78–144) 106 (73–136)
Unsaturated fatty acids (gram/day)a 50 (40–62) 48 (40–60) 47 (38–57)
Saturated fatty acids (gram/day)a 37 (30–45) 35 (28–43) 32 (26–39)
Alcohol consumption (gram/day)a 7 (1–17) 8 (2–19) 8 (2–20)
a Numbers are given as mean (sd) or as median (interquartile range); b Low educational level: lower vocational 
training or primary school.
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table 3.2 Hazard ratios (95% cI) of baseline and updated mean Mediterranean diet score in relation 
to composite and fatal cVd. the doetinchem cohort study
 MDS
 0–3.5 3.5–5.5 5.5–9
composite cVd    
Persons at risk, n  673 1,541 1,203
Cases, n 52 87 67
Baseline MDS 1.00 (ref) 0.72 (0.51–1.02) 0.77 (0.53–1.11)
Updated mean MDS 1.00 (ref) 0.68 (0.46–1.00) 0.65 (0.43–0.97)
Fatal cVd
Persons at risk, n 664 1,513 1,180
Cases, n 9 16 13
Baseline MDS 1.00 (ref) 0.80 (0.35–1.82) 0.87 (0.36–2.07)
Updated mean MDS 1.00 (ref) 0.40 (0.17–0.93) 0.44 (0.19–1.05)
All analyses are adjusted for age, sex, smoking, sports, energy intake, and educational level. Analyses with 
baseline MDS as exposure were adjusted for the baseline levels of the confounders. Analyses with the 
updated mean MDS were adjusted for the most recent level of the confounders.
table 3.3 Hazard ratios (95% cI) of baseline and updated mean Mediterranean diet score in relation 
to composite and fatal cVd; different ways of adjustment. the doetinchem cohort study
 MDS
 0–3.5 3.5–5.5 5.5–9
composite cVd
Persons at risk, n (round 2) 673 1,541 1,203
Cases, n (round 2) 52 87 67
Updated mean MDS
Model 1 1.00 (ref) 0.66 (0.45–0.96) 0.58 (0.39–0.86)
Model 2 1.00 (ref) 0.70 (0.48–1.03) 0.68 (0.45–1.02)
Model 3 1.00 (ref) 0.68 (0.46–1.00) 0.65 (0.43–0.97)
Fatal cVd
Persons at risk, n (round 2) 664 1,513 1,180
Cases, n (round 2) 9 16 13
Updated mean MDS
Model 1 1.00 (ref) 0.40 (0.17–0.92) 0.43 (0.18–1.00)
Model 2 1.00 (ref) 0.43 (0.19–1.00) 0.50 (0.21–1.20)
Model 3 1.00 (ref) 0.40 (0.17–0.93) 0.44 (0.19–1.05)
Model 1: adjusted for age and sex; 
Model 2: Model 1 + baseline smoking, sports, energy intake, and educational level;
Model 3: Model 1 + most recent smoking, most recent sports, updated mean energy intake, and educational 
level.
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HR of 0.65 (0.43–0.97) for the association between updated mean MDS and composite CVD, 
while adjustment for the baseline level of the confounders resulted in a HR of 0.68 (0.45–1.02). 
For fatal CVD, adjustment for the most recent levels of the confounders resulted in a HR of 
0.44 (0.19–1.05), while adjustment for baseline level of the confounders resulted in a HR of 
0.50 (0.21–1.20).
dIscussIon
This study showed that the updated mean of three measurements of a Mediterranean style 
diet over 10 years compared with the baseline measurement resulted in stronger associations 
and smaller confidence intervals for composite and fatal CVD. In contrast to our hypothesis, 
using the most recent levels of potential confounders did not attenuate the strength of the 
associations further.
We observed stronger associations of a Mediterranean style diet in relation to CVD for 
the updated mean of three measurements over 10 years compared to using the baseline 
measurement only. Other cohort studies on dietary patterns6,7 or food groups3 observed 
in sensitivity analyses ‘similar’ or ‘similar but weaker’ associations when using the baseline 
instead of the updated mean of dietary intake. Because these studies provided only the effect 
estimates of the updated mean and not of the baseline measurements, we were not able to 
compare the results quantitatively. In the present study, the updated mean reduced random 
measurement error and therefore resulted in less attenuation of the regression coefficients 
resulting in stronger associations. It is also possible that the updated mean, which reflects 
long-term diet, is etiologically more relevant than the most remote (baseline) measurement of 
the diet. We observed larger differences between the results for baseline compared to updated 
MDS in association with fatal CVD than for composite CVD. This may be explained by less 
misclassification for fatal than for non-fatal CVD cases.17 
We observed only minor differences in the associations of MDS with CVD endpoints when the 
most recent levels of confounders were used instead of baseline values only. This may be due 
to the limited changes in smoking and sports behaviour in our population. Only 13% of the 
total population changed smoking habits during 10 years of follow-up, and 36% changed their 
sports behaviour. Daily energy intake changed during follow-up, however, adjustment for daily 
energy intake hardly attenuated our associations. Hu et al. also noted that the use of baseline 
or updated covariates yielded similar results.1
Although median MDS remained stable in the present study, individuals changed their level of 
adherence to the MDS in the different rounds. About 55% of the participants had a change of 
at least two MDS points between subsequent rounds. Using only baseline MDS likely resulted 
in misclassification of dietary intake of these people. The Spearman correlation coefficient was 
0.47 for the MDS at baseline and after five years, and 0.39 for the MDS at baseline and after 
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ten years. These are low correlations compared to the study of Sijtsma et al. who observed 
correlation coefficients around 0.6 for time periods of 7–20 years for an a-priori diet score of 
the ‘whites’ in the CARDIA-study.18 Correlation coefficients between repeated measurements 
of dietary patterns observed in the CARDIA study were similar to those of serum cholesterol 
and blood pressure.18,19 
We quantified for the first time the effect of updated mean measurements of a dietary pattern 
score on the strength of the association with CVD compared to the baseline measurement. A 
limitation of our study is that the results for fatal CVD were based on only 38 cases, resulting 
in large and overlapping confidence intervals. Therefore, our study should be repeated in other 
cohorts. The present study also has advantages. The food frequency questionnaires, as well as 
the questions on the covariates remained the same during 10 years of follow-up. In addition, 
our study was performed in a general population sample.
In conclusion, the present study showed that the use of multiple measurements of the 
Mediterranean Diet Score increased the strength of the associations with composite and fatal 
CVD and narrowed the confidence intervals of these associations. Therefore, it is likely that 
the association has been underestimated because most studies so far used only the baseline 
measurement.
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AbstrAct 
Background: Physical activity is inversely related to cardiovascular diseases. However, the 
type of activities that contribute most to these beneficial effects remain unclear. For this 
reason, we investigated self-reported leisure time physical activities in relation to fatal/
non-fatal cardiovascular disease incidence. 
Design: The Dutch Monitoring Project on Risk Factors for Chronic Diseases (MORGEN 
Study), carried out between 1993 and 1997, is a prospective cohort study of over 23,000 
men and women aged 20–65 years from the general Dutch population. 
Methods: From 1994 until 1997 physical activity was assessed with a questionnaire in 7,451 
men and 8,991 women who were followed for an average of 9.8 years. Cox Proportional 
Hazards models were used adjusting for age, sex, other physical activities, smoking, 
alcohol consumption and educational level. 
Results: Almost the entire study population (97%) was engaged in walking, about 75% in 
regular cycling and about half the population in sports or gardening. Cycling (HR: 0.82; 
95% CI: 0.71–0.95) and sports (HR: 0.74; 95% CI: 0.64–0.87) were both inversely related 
to cardiovascular disease incidence, whereas walking and gardening were not. For sports 
(p<0.001), but not for cycling (p=0.06), we observed a dose−response relationship with 
respect to cardiovascular disease incidence. Engaging in both cycling and sports resulted 
in an even greater risk reduction (HR: 0.64; 95% CI: 0.52–0.77). 
Conclusions: In this relatively active population, types of activities of at least moderate 
intensity, such as cycling and sports, were associated with lower CVD incidence, whereas 
activities of lower intensity, such as walking and gardening, were not. 
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IntroductIon 
Over the past few decades, many epidemiological studies have demonstrated a clear inverse 
association between physical activity and cardiovascular diseases (CVD).1 In a recent meta-
analysis, including almost 900,000 participants, physical activity was associated with a 35% lower 
risk of fatal CVD when comparing active with inactive individuals.1 Early studies focused mainly 
on occupational physical activity and total physical activity. Over the years, however, interest 
has shifted towards daily leisure time physical activities, such as walking and cycling, because 
of a wider range of activities that are also easier to modify than occupational physical activities. 
Therefore leisure time physical activities make a suitable target for public health promotion. 
Several investigations have observed associations between leisure time physical activity and 
CVD.2,3 However, it remains unclear what specific type of activities contribute most to these 
beneficial effects, since few studies have addressed the impact of different types of activities on 
CVD.4-6 For this reason, we aimed at investigating specific types of leisure time physical activity 
(walking, gardening, cycling and sports) in relation to CVD incidence in a population-based 
sample of the Dutch population aged 20–65 years at baseline. We evaluated dose–response 
relationships and the impact of combinations of different types of activities.
Methods
study population
The MORGEN Study was carried out in the Netherlands between 1993 and 1997 in 10,448 men 
and 12,652 women. Random sex−age stratified samples were drawn from municipal population 
registers in three towns in the Netherlands (Doetinchem, Maastricht and Amsterdam). The 
average response rate in the MORGEN Study was 45%.7 
From 1994 until 1997 physical activity was assessed with an identical questionnaire for 8,142 
men and 9,778 women. Exclusion criteria for the present analyses were no informed consent 
for follow-up of vital status (n=1,017), pregnancy at baseline (n=106), prevalent myocardial 
infarction or stroke (n=342) and missing data on physical activity (n=13). After these exclusions, 
7,451 men and 8,991 women remained for the present analyses. 
Measurements
Questionnaires
Physical activity was assessed with a validated8 physical activity questionnaire designed for the 
“European Prospective Investigation into Cancer and nutrition” (EPIC) including questions on 
occupational and leisure time physical activity. The question on cycling included cycling towards 
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and from work and in leisure time as an example and the question on walking additionally 
included shopping as an example. For the MORGEN Study, the questionnaire was extended with 
two open-ended questions on type, frequency, and duration of sports, and one open-ended 
question on other strenuous activities. 
A Dutch reproducibility and validity study showed that the EPIC questionnaire was suitable for 
ranking participants according to their physical activity level.8 The 11-month reproducibility 
(Spearman correlation coefficients) of the questionnaire for men yielded: 0.57 for walking, 0.47 
for cycling, and 0.71 for gardening and for women, 0.57, 0.72, and 0.67, respectively.8 Spearman 
correlation coefficients relative to a three-day activity diary, repeated four times, were, for men: 
0.32 for walking, 0.46 for cycling, and 0.43 for gardening and odd jobs and for women, 0.33, 
0.48, and 0.47, respectively.8 
In general, health effects may be expected from at least moderate intensity physical activity,9 
which in the Netherlands has been defined as at least 4.0 metabolic equivalents (METs).10 
Although walking (3.5 METs) does not classify as ‘moderate intensity’ in the Netherlands, this 
activity has repeatedly been shown to be associated with reduced risk of CVD.11-13 Moreover, 
walking is an important leisure time activity in the Netherlands, both in terms of frequency and 
duration. Therefore, we investigated walking (Ainsworth code: 1725014; 3.5 METs), gardening 
(Ainsworth code: 0824514; 4.0 METs), cycling (Ainsworth code: 0201014; 7.0 METs), and sports 
(≥4.0 METs) as specific types of leisure time physical activity possibly related to CVD.
Time spent on occupational physical activities (continuous) of at least moderate intensity was 
included as confounder. Gardening, cycling and sports were classified as ‘yes’, or ‘no’. Since 97% of 
all participants reported at least some walking, participants who reported <3.5 hr/wk (30 minutes 
per day) were used as the reference category for walking. To study dose–response relationships, 
we divided cycling and sports into three categories (0 hr/wk, >0–3.5 hr/wk, and ≥3.5 hr/wk).
Educational level was classified as low (lower vocational training or primary school), medium 
(secondary school and intermediate vocational training), or high (higher vocational training or 
university). Smoking was categorized as yes or no, and alcohol consumption as none, moderate 
(male: ≤2 glasses / female: ≤1 glass per day), or high (male: >2 glasses / female: >1 glass 
per day). Self-reported CVD risk factor medication was defined as using cholesterol lowering 
medication or antihypertensive agents.
Physical examination
Weight and height were measured to the nearest 0.1 kg and 0.5 cm without shoes. Body Mass 
Index (BMI) was calculated as weight in kilograms (minus one kilogram for light clothing) divided 
by height in meters squared. BMI was classified as normal (<25 kg/m2), overweight (25–30 kg/
m2), or obese (≥30 kg/m2). Non-fasting plasma total cholesterol and HDL cholesterol were 
determined in the Lipid Reference Laboratory of the University Hospital Dijkzigt in Rotterdam 
using standardized enzymatic methods.15 Systolic blood pressure was recorded twice with a 
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Random Zero Sphygmomano-meter at the appearance of sounds (first-phase Korotkoff) in sitting 
position.15 The average of the two blood pressure measurements was included in current analyses.
Ascertainment of fatal and non-fatal events
Information on mortality and morbidity follow-up was available up to January 1st 2006. Vital 
status was identified using the municipal population register with a loss-to-follow-up below 
0.1%. Cause of death was obtained from Statistics Netherlands and morbidity data were provided 
by the national hospital discharge register (HDR). On the national level, at least 88% of the 
hospital admissions can be uniquely linked to a single person.16 In a validation study with an 
approximate 33% overlap of participants from our study, a high sensitivity (84%) and a positive 
predictive value (97%) were observed for CHD hospital admissions.17 
Fatal (primary or secondary cause of death) and non-fatal CVD were defined according to ICD-918, 
codes 410–414, 415.1, 427.5, 428, 430–438, 440–444, 798.1, 798.2 and 798.9 and corresponding 
ICD-1019 codes for the fatal cases after 1996. 
statistical analyses
Cox Proportional Hazards models were used to estimate hazard ratios and 95 percent confidence 
intervals. Participants were either followed up to the first non-fatal cardiovascular event, death, 
emigration, or were censored at January 1st 2006.
Three consecutive models were used. The first model was adjusted for age and sex. The 
second model was additionally adjusted for hours per week spent on physical activities (both 
occupational and leisure time) other than the one under study, lifestyle factors (smoking and 
alcohol consumption), and educational level. Since biological risk factors such as BMI, total 
and HDL cholesterol, and systolic blood pressure are possible intermediates in the association 
between physical activity and CVD, we additionally adjusted for these factors in a third model. 
Since no difference occurred in the hazard ratios, we will report only the hazard ratios of the 
second model. There was no interaction with age (younger or older than 50 years), nor with sex 
and the proportional hazard assumption was satisfied. To study dose–response relationships, we 
performed tests for linear trend using the median values of the respective category as continuous 
parameters. Analyses were performed using SAS 9.1 software (SAS Institute, INC., Cary, NC).
results
Baseline characteristics of the study population are shown in table 4.1. Participants were, on 
average, 41.9 ± 11.2 years old at baseline, and 45% were male. Walking and cycling contributed 
the most to the time spent on leisure time physical activities. Almost the entire study population 
was engaged in walking (97%), about 75% in regular cycling and about half of the population 
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in gardening or sports. Intensities of sports ranged from 4.0 to 12.0. table 4.2 shows the 10 
most frequently reported sports for men and women. During 9.8 years of follow-up, 362 fatal 
and non-fatal CVD events occurred in women, compared to 561 in men.
table 4.1 characteristics of participants in the MorGen study, 1994–1997a,b
 Men 
(n=7,451)
Women 
(n=8,991)
demographic factors
Age (years) 42.4 (11.1) 41.6 (11.4)
Education (%)c
Low 41.9 50.9
Medium 30.2 26.9 
High 28.0 22.2
leisure time physical activity (%)
Walking (3.5 MET) 96.4 96.5
Gardening (4.0 MET) 54.5 51.7
Cycling (7.0 MET) 74.7 78.0
Sports (≥4.0 MET) 42.5 41.1
lifestyle factors (%)
Current smoking 35.2 35.5
Alcohold
Never/former 8.5 18.2
Moderate 56.9 57.5
High 34.6 24.2
biological risk factors
BMI (kg/m2) 25.4 (3.6) 24.7 (4.3)
Total cholesterol (mmol/l) 5.3 (1.1) 5.2 (1.0)
HDL cholesterol (mmol/l) 1.2 (0.3) 1.5 (0.4)
Systolic blood pressure (mmHg) 125 (15) 118 (16)
Self-reported CVD risk factor medication (%)e 5.2 5.4
cardiovascular cases (n)
Fatal CVD 66 28
Coronary heart disease 38 10
Stroke 7 9
Non-fatal CVD 526 346
Coronary heart disease 340 196
Myocardial infarction 116 61
Angina pectoris 117 71
Stroke 77 63
BMI, body mass index; HDL, high-density lipoprotein; CVD, cardiovascular disease. 
 a With consent for follow-up and free from baseline CVD, pregnancy and without missing data on physical 
activity, n=16,442; b Data presented as mean (sd); c low (lower vocational training or primary school), medium 
(secondary school and intermediate vocational training), high (higher vocational training or university); 
d Moderate (male: ≤2 glasses / female: ≤1 glass per day), high (male: >2 glasses / female: >1 glass per 
day); e Cholesterol-lowering and/or antihypertensive medication. 
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Walking or gardening were not associated with CVD incidence. Inverse associations with CVD 
incidence were observed for cycling (HR: 0.82; 95% CI: 0.71–0.95) and sports (HR: 0.74; 95% CI: 
0.64–0.87) (table 4.3). Cycling for up to 3.5 hr/wk was protective (HR: 0.82; 95% CI: 0.69–0.97) 
compared to not cycling, but cycling for 3.5 hr/wk or more did not give additional protection (p for 
trend=0.06) (Figure 4.1). The dose–response relationship was more pronounced for sports than 
for cycling. Engaging in sports for up to 3.5 hr/wk resulted in a 23% lower risk for CVD incidence 
(HR: 0.77; 95% CI: 0.65–0.91) and in a 34% (HR: 0.66; 95% CI: 0.50–0.88) lower risk when more 
than 3.5 hr/wk were spent on sports, compared to not engaging in sports (p for trend <0.001). 
Engaging in both cycling and sports increased the protective effect of these separate types 
of activities on CVD incidence (Figure 4.2). The HR for engaging in cycling, but not in sports, 
was 0.83 (95% CI: 0.70–0.97), for sports, but no cycling, 0.73 (95% CI: 0.53–0.99), and for both 
cycling and sports 0.64 (95% CI: 0.52–0.77).
table 4.2 ten most frequent reported sports for men and women in the MorGen study
Sport
Ainsworth 
code (2000)a
Intensity 
(MET)a Ainsworth descriptiona
n men or 
women
% men or 
woman
Men
soccer 15610 7 soccer, casual, general 690 9
tennis 15675 7 tennis, general 624 8
swimming 18310 6 swimming, leisurely, not lap 
swimming, general
412 6
jogging 12020 7 jogging, general 401 5
running 12150 8 running 363 5
aerobic fitness 2060 5.5 health club exercise, general 352 5
volleyball 15710 4 volleyball 240 3
squash 15650 12 squash 195 3
badminton 15030 4.5 badminton, social singles 
and doubles, general
177 2
snowboarding 19160 6 skiing, downhill, moderate 
effort, general
152 2
Women
swimming 18310 6 swimming, leisurely, not lap 
swimming, general
995 11
aerobics 3015 6.5 aerobic dancing, general 742 8
tennis 15675 7 tennis, general 640 7
fitness for 
strength
2030 6 calisthenics, home exercise, 
light or moderate effort
435 5
gymnastics 15300 4 gymnastics, general 420 5
aerobic fitness 2060 5.5 health club exercise, general 371 4
jogging 12020 7 jogging, general 245 3
volleyball 15710 4 volleyball 230 3
snowboarding 19160 6 skiing, downhill, moderate 
effort, general
200 2
mountain walking 17210 6 walking, 3.5 mph, uphill 181 2
a This information was derived from Ainsworth et al.14
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dIscussIon
In this relatively active population, cycling and sports were both inversely associated with CVD 
incidence, but walking and gardening were not. For sports, but not for cycling, a dose–response 
relationship was observed with CVD incidence. Furthermore, the results of our study suggest 
that engaging in both cycling and sports was strongly related to CVD incidence. 
Our results showed that specific leisure time physical activities of higher intensity, such as 
cycling and sports, were inversely associated with CVD incidence in contrast to activities of 
lower intensity, such as walking and gardening. Moderate to vigorous intensity physical activity 
has been hypothesized to reduce blood pressure, improve the blood lipid profile, endothelial 
function, lower systemic inflammation, and to have an anti-thrombotic effect and will thereby 
lower the damage due to atherosclerosis of the cardiac, cerebral, and peripheral blood vessels.20,21 
Since adjustments for blood pressure, HDL and total cholesterol in our investigation had no 
influence on the associations of the activities with CVD incidence, these factors cannot explain 
our results. We were not able to asses the effects of systemic inflammation, endothelial function, 
and the antithrombotic effect on our results.
Several large prospective investigations and a recent meta-analysis observed inverse associations 
between walking and CVD11-13 but we did not find an association. A possible explanation could 
be that in our investigation the validity of walking is lower than for the other activities, which 
table 4.3 hazard ratios of walking, gardening, cycling and sports in relation to cVd incidence in 
participants aged 20–65 years at baseline in the MorGen study, 1994–1997a 
  CVD
  
n at 
risk
n 
cases
Person 
years  Model 1b Model 2c
Walking <3.5 hr/wk 3,464 196 33,503 1.00 -- 1.00 --
≥3.5 hr/wk 12,978 727 124,169 1.07 (0.91–1.25) 1.06 (0.91–1.25)
Gardening No 7,735 397 73,960 1.00 -- 1.00 --
Yes 8,707 526 83,712 0.90 (0.79–1.03) 0.94 (0.83–1.08)
Cycling No 3,862 290 36,547 1.00 -- 1.00 --
Yes 12,580 633 121,125 0.74 (0.65–0.86) 0.82 (0.71–0.95)
Sportsd No 9,581 672 91,461 1.00 -- 1.00 --
Yes 6,861 251 66,211 0.67 (0.58–0.77) 0.74 (0.64–0.87)
a Participants were followed up to January 1st 2006; b Adjusted for age (continuous) and sex; c Additionally 
adjusted for other physical activities (both occupational and leisure) than the one under study, current 
smoking (yes, no), alcohol consumption (never/former, moderate, or high) and educational level (low, 
medium, or high); d Sports ≥4.0 METs.
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Figure 4.1 dose–response relationship between sports, cycling and cVd incidence. 
Model 1 was adjusted for age (continuous) and sex; model 2 was additionally adjusted for other physical 
activities (both occupational and leisure) than the one under study, current smoking (yes, no), alcohol 
consumption (never/former, moderate, or high) and educational level (low, medium, or high). 
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Figure 4.2 hazard ratios of cVd incidence for the combination of cycling and sports with no cycling 
and sports as reference category. 
Model 1 was adjusted for age (continuous) and sex; model 2 was additionally adjusted for other physical 
activities (both occupational and leisure) than the one under study, current smoking (yes, no), alcohol 
consumption (never/former, moderate, or high), and educational level (low, medium, or high).
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might have attenuated an existing association. However, activities of lower intensity generally 
have lower reproducibility and validity than activities of higher intensity.13 Therefore, the lower 
validity of walking cannot fully explain the lack of association in the present study where others 
have observed an association. The most likely explanation for not finding an association is 
that almost everybody walked. Only 3% of our population did not walk at all, and 21% walked 
less than 3.5 hours per week or 30 minutes per day. The mean walking duration among those 
who reported any walking in the present study was 13.6 ± 12.2 hrs/wk and the median 9.0 
(interquartile range: 4.0–20.0) hrs/wk. One of the reasons for this high frequency and duration 
of walking could be that walking was assessed in a broad sense e.g. not only taking a walk but 
also walking for transportation, shopping and walking at work.4,6  In a population with a walking 
pattern comparable to the current population, no association with CVD was observed,5 which 
suggests that walking lowers risk in relatively inactive populations only. 
Consistent with our finding, Andersen et al. observed a 38% lower risk of all cause mortality for 
cycling on average three hours per week compared to not cycling.22 We found only two studies 
investigating the independent association between cycling and CVD.5,6 These investigations did 
not find any associations, which might be due to the limited number of participants cycling a 
substantial amount of time. The protective association we observed for sports in relation to 
CVD is consistent with the literature.4,5,23-25
This study had some limitations. First, physical activity was recorded only at baseline. Second, 
as in most other prospective studies, our results were based on self-reported physical activity. 
Although our questionnaire was shown to be reproducible and valid,8 recall and social desirability 
bias may have occurred. Especially for a low intensity activity as walking recall bias is possible. 
Both limitations could have resulted in bias towards the null hypothesis. A major strength of 
the present study is the large study population of relatively young (20–65 years) and active men 
and women from the Netherlands. The Netherlands is a country with a relatively high level of 
physical activity compared to other countries.26,27 Moreover, we were able to study cycling in 
detail, since cycling is a frequently used means of transportation in the Netherlands. Another 
strength is the extensive physical activity questionnaire which made it possible to address 
several individual leisure time physical activities simultaneously. Only few studies have reported 
multiple separate types of activities in relation to CVD. Furthermore, the comprehensive data 
collection made it possible to adjust for several confounders. 
We conclude that in this relatively active population, types of activities of at least moderate 
intensity, such as cycling and sports, were associated with lower CVD incidence, whereas 
activities of lower intensity, such as walking and gardening, were not. Engaging in both cycling 
and sports gave the greatest risk reduction, and may therefore be a good way to prevent CVD.
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AbstrAct 
Study objectives: We studied sleep duration and sleep quality in relation to cardiovascular 
disease (CVD) incidence. 
Design/setting: Dutch population-based cohort study. 
Participants: 20,432 men and women aged 20–65 y with no history of CVD. 
Interventions: N/A 
Measurements: Sleep duration and sleep quality were assessed by a self-administered 
questionnaire. Morbidity data, vital status, and causes of death were obtained through 
linkage with several national registries. Hazard ratios (HRs) and 95% confidence intervals 
(95% CIs) were calculated using Cox proportional hazards models.
Results: During 10–15 years of follow-up, 1,486 CVD and 1,148 coronary heart disease 
(CHD) events occurred. Short sleepers (≤6 h) had a 15% higher risk of total CVD (HR: 1.15; 
95% CI: 1.00–1.32) and a 23% higher risk of CHD (HR: 1.23; 95% CI: 1.04–1.45) compared 
to normal sleepers (7 h) after adjustment for all confounders. Additional adjustment for 
intermediate biological risk factors attenuated these relative risks to 1.11 (0.97–1.27) for 
total CVD and to 1.19 (1.00–1.40) for CHD. Short sleepers with poor sleep quality had 
a 63% higher risk of CVD (HR: 1.63; 95% CI: 1.21–2.19) and a 79% higher risk of CHD 
incidence (HR: 1.79; 95% CI: 1.24–2.58) compared to normal sleepers with good sleep 
quality, after adjustments for all confounders. We observed no associations between long 
sleep duration (≥9 h) and CVD or CHD incidence. 
Conclusions: Short sleepers, especially those with poor sleep quality, have an increased 
risk of total CVD and CHD incidence. Future investigations should not only focus on sleep 
duration, but should also take sleep quality into account. 
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IntroductIon 
Cohort studies reported conflicting results for the association of short sleep duration with the 
occurrence of cardiovascular diseases (CVD). In a recent meta-analysis incorporating 15 studies 
by Cappuccio et al.,1 short compared to normal sleep duration was not related to total CVD 
(RR: 1.03 [95% CI 0.93–1.15]), though it was related to coronary heart disease (CHD) (RR: 1.48 
[1.22–1.80]) and stroke (RR: 1.15 [1.00–1.31]). For long compared to normal sleep duration, 
Cappuccio et al reported an RR of 1.41 (1.19–1.68) for total CVD, 1.38 (1.15–1.66) for CHD, and 
1.65 (1.45–1.87) for stroke.1
The relation between short sleep duration and CVD incidence could be due to an effect of short 
sleep on intermediate biological CVD risk factors such as BMI, blood lipids, high blood pressure, 
and prevalence of diabetes.2-4 The association between long sleep duration and CVD incidence 
may be explained by long sleep duration being an early symptom of disease and preceding 
clinical diagnoses.2 Also, sleep quality may modify the association between sleep duration and 
CVD. Sleep quality is an important factor in the physiologic recovery of the body during sleep, 
and good sleep quality may prevent CVD.5 Therefore, short and long sleep duration may be 
adequate for those with good sleep quality but not for those with poor sleep quality. Chandola 
et al. were the first to demonstrate that the association between short sleep duration and CHD 
was strongest among those with sleep disturbance.6 
The purpose of the present study was to investigate the association between short and long 
sleep duration and total CVD and CHD incidence, independent of lifestyle related factors, 
subjective health and educational level. We investigated mediation by biological CVD risk factors 
by adjusting for these factors. In a subsample of our population, we explored the combined 
associations of sleep duration and sleep quality with CVD and CHD incidence.
Methods
study population
The MORGEN Study (Monitoring Project on Risk Factors and Chronic Diseases in the Netherlands) 
was carried out in the Netherlands between 1993 and 1997 in 23,033 participants (10,422 men 
and 12,611 women). Random sex- and age-stratified samples were drawn from municipal 
population registers in 3 towns in the Netherlands (Doetinchem, Maastricht, and Amsterdam). 
The average response rate in the MORGEN Study was 45%.7 We excluded participants with 
prevalent CVD based on self-report and hospital admission data, women who were pregnant 
at baseline, those with no information on sleep duration, sleep quality, or any of the covariates, 
as well as those with no follow-up of vital status or of cardiovascular events. In total 20,432 
participants 9,217 men and 11,215 women remained for our analyses. The Medical Ethics 
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Committee of the Netherlands Organization for Applied Scientific Research (TNO) approved 
the study protocol and all participants signed an informed consent form. 
sleep duration and sleep quality
Information on sleep duration and on sleep quality was obtained by a self-administered 
questionnaire. The average sleep duration was assessed by asking “How many hours of sleep 
do you usually get per 24-hour period?” with answer categories “5 hours or less,” “6 hours,” “7 
hours,” “8 hours,” and “9 hours or more.” Short sleep duration was defined as sleeping ≤6 h, 
normal sleep duration as 7 (reference group) or 8 h, and long sleep duration as ≥9 h. 
Information on sleep quality was obtained only in the first 2 years of baseline measurements (1993 
and 1994; n=8,341) as part of the Amsterdam Biographical Questionnaire on neuroticism.8 It was 
assessed by asking “Do you usually rise rested?” with answer categories “yes,” “don’t know,” or “no”. 
“Good sleep quality” was defined as “yes” for rising rested and “poor sleep quality” was defined 
as “no” for rising rested. We excluded those answering “don’t know” (n=1,658, 20%) from the 
analyses regarding sleep quality. Thus 6,683 participants remained for our analyses on sleep quality.
Ascertainment of non-fatal and fatal cVd and chd events
After enrolment in the MORGEN Study, the participants were followed for the occurrence of 
non-fatal and fatal CVD and CHD by linkage with registries. Morbidity data were provided by 
the National Medical Registry (NMR) using the Dutch Hospital Discharge Diagnosis Database 
(HDR).Vital status was obtained through linkage with the municipal population registries. 
Subsequently, primary and secondary causes of death were obtained through linkage with 
“Statistics Netherlands.” Information on morbidity and mortality follow-up was available up to 
January 1, 2008.7 Non-fatal and fatal CVD were defined according to ICD-99 codes 410– 414, 
415.1, 427.5, 428, 430–438, 440–444, 798.1, 798.2, and 798.9; or ICD-1010 codes G45, I21–I26, 
I46, I50, I60–I67, I69 I70–I74, R96 for the fatal cases after 1996. CHD was defined as ICD9 codes 
410–414 or ICD10 codes I20–I25.
covariates
Information on educational level, current smoking, physical activity, alcohol and coffee 
consumption, subjective health and CVD risk factor medication were assessed by a self-
administered questionnaire. Educational level was assessed as the highest level of education 
reached. Smoking was assessed as “yes,” “no,” or “former.” Information on physical activity was 
assessed with the validated11 and extended12 EPIC questionnaire during the period 1994–1997. 
We included cycling and sports as covariates, since in our population only those two activities 
were inversely associated with CVD incidence.12 Subjective health was assessed by a self-
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administered questionnaire by asking “How do you rate your health in general?” with five 
answer categories ranging from “excellent” to “bad.” Self-reported CVD risk factor medication 
was defined as using cholesterol lowering medication or antihypertensive agents. Prevalent 
cases of diabetes were identified through linkage with the Dutch HDR (1990–97) and by self-
report. Cases detected by either of these methods were verified by consulting medical records of 
general practitioners.7 Standardized measurements of weight, height, and systolic and diastolic 
blood pressure were obtained, and blood was drawn by trained personnel during a visit to 
the municipal health service. Non-fasting plasma glucose and total and HDL cholesterol were 
measured with commonly used methods. A more detailed description of these measurements 
has previously been published by Beulens et al.7 
statistical analyses
Statistical analyses were carried out using SAS statistical software version 9.2 (SAS Institute, INC., 
Cary, NC). Participants’ characteristics are presented as mean ± SD for continuous variables, or 
percentages for categorical variables, in strata of sleep duration categories. Participants were 
followed up to the first non-fatal cardiovascular event, death, emigration, or were censored at 
January 1, 2008, whichever came first. Cox proportional hazards models were used to estimate 
hazard ratios (HRs) and 95% confidence intervals (95% CIs) of total CVD and CHD incidence 
in sleep categories. Participants with a normal sleep duration of 7 h were considered as the 
reference group. The Cox proportional hazard assumption was fulfilled according to the graphical 
approach and according to Schoenfeld residuals.
To assess sleep duration and sleep quality in relation to total CVD and CHD incidence, four models 
were used. The first model was adjusted for age and sex. In the second model we additionally 
included current smoking (yes, no), alcohol consumption (male: none, >0–2, >2 glasses per day/ 
female: none, >0–1, >1 glass per day) and coffee consumption (<6, ≥6 cups a day) in the model. 
In the third model we additionally included educational level (low [lower vocational training 
or primary school], medium [secondary school and intermediate vocational training], or high 
[higher vocational training or university]) and subjective health (bad-reasonable, good-excellent). 
In the fourth model we assessed mediation by biological risk factors, by additionally adjusting 
for BMI (continuously), total-/HDL cholesterol ratio, systolic blood pressure (continuously), CVD 
risk factor medication (yes, no), and prevalent type 2 diabetes (yes, no). 
To test for interaction in the association between sleep duration and total CVD with age (younger 
or older than 50 years), sex, current smoking, hypertension, BMI categories (<25, 25–30, ≥30 kg/
m2) and sleep quality, we added interaction terms to models adjusted for age and sex. Only the 
interaction term between sleep quality and sleep duration was statistically significant at α<0.05.
To minimize the possibility that sleeping habits have changed in response to subclinical disease, the 
analyses were repeated after exclusion of cases in the first 2 years of CVD follow-up. Additionally, 
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sensitivity analyses were performed in which participants with underweight (BMI <18.5; n=327), 
prevalent diabetes (n=189), and those with CVD risk factor medication (n=1,015) were excluded.
results
During 10–15 years of follow-up (mean 11.9 years) 1,486 total CVD events and 1,148 CHD events 
occurred. In total 3,387 (17%) participants were short sleepers, and 1,480 (7%) long sleepers. At 
baseline, short sleepers were generally older, more likely to be male, and had a less favorable 
risk profile than normal sleepers (table 5.1). Long sleepers were of the same age, less likely to 
be male, had less favorable levels of lifestyle factors, and similar levels of biological risk factors 
compared to normal sleepers. 
After adjustment for relevant confounders (age, sex, lifestyle factors, subjective health, and 
educational level; model 3), short sleepers had a 15% higher risk of total CVD incidence (HR: 
1.15; 95% CI: 1.00–1.32) and a 23% higher risk of CHD incidence (HR: 1.23; 95% CI: 1.04–1.45) 
compared to normal sleepers (table 5.2). In the subgroup of participants with information on 
physical activity (n=16,183), additional adjusting for cycling (yes, no) and sports (yes, no)12 did 
not further attenuate the association (results not shown). Adjustment for intermediate biological 
risk factors (BMI, total-/HDL cholesterol ratio, systolic blood pressure, CVD risk factor medication, 
and prevalent type 2 diabetes; model 4) diminished the relative risks to 1.11% for total CVD 
incidence (HR: 1.11; 95% CI: 0.97–1.27) and to 1.19% for CHD incidence (HR: 1.19 [1.00–1.40]). 
Long sleep duration was not associated with total CVD incidence (HR: 0.94; 95% CI: 0.76–1.16; 
model 3), although long sleepers tended to have a lower risk of CHD incidence (HR: 0.77; 95% 
CI: 0.58–1.02; model 3). 
In a subgroup of 6,683 participants data was available on sleep quality. After adjustment for age 
and sex, participants with poor sleep quality had a 22% (HR: 1.22; 95% CI: 1.02–1.44) higher risk 
of CVD and a 34% (HR: 1.34; 95% CI: 1.08–1.66) higher risk of CHD incidence than those with 
good sleep quality (table 5.3). After additional adjustment for sleep duration, lifestyle factors, 
subjective health, and educational level, this higher risk was no longer statistically significant 
(HR CVD: 1.05; 95% CI: 0.87–1.26/ HR CHD: 1.18; 95% CI: 0.94–1.49). Interactions between sleep 
duration and sleep quality in relation to CVD and to CHD were significant (both p<0.05). After 
adjustment for all relevant confounders and compared to participants with a normal sleep 
duration and good sleep quality, those with short sleep duration or with poor sleep quality were 
not at higher risk of CVD or CHD incidence, whereas those with both short sleep duration and 
poor sleep quality had a 63% higher risk of CVD (HR: 1.63; 95% CI: 1.21–2.19) and a 79% higher 
risk of CHD incidence (HR: 1.79; 95% CI: 1.24–2.58) (Figure 5.1). Among short sleepers, in our 
full model (adjusted for age, sex, smoking, alcohol consumption, coffee, subjective health, and 
educational level) we observed an HR of 1.32 (95% CI: 0.95–1.84) for poor compared to good 
quality in relation to total CVD and an HR of 1.57 (95% CI: 1.05–2.36) for CHD.
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table 5.1 baseline characteristics of men and women; the MorGen study, 1993–1997
 Sleep duration
 ≤6 h
(n=3,387)
7 h
(n=8,216)
8 h
(n=7,349)
≥9 h
(n=1,480)
demographic factors
Age (years)a 44.3 (10.3) 41.7 (10.6) 41.5 (11.8) 41.4 (12.9)
Sex (male, %) 54 50 38 32
Education (%)
Low 54 44 49 57
lifestyle factors (%)
Current cigarette smoking 40 35 33 35
Cycling b 70 80 79 72
Sportsb 36 46 43 36
Alcohol 
None 15 10 15 23
Moderatec 52 58 60 54
Coffee consumption (≥6 cups a day) 44 39 31 28
General health (%)    
Good subjective health 82 92 91 79
Sleep qualityd
Good 39 53 58 44
Don't know 21 21 19 16
Poor 40 26 24 40
biological risk factors
BMI (kg/m2)a 25.7 (4.1) 24.9 (3.8) 24.8 (3.9) 24.9 (4.3)
Overweight (25–30 kg/m2, %)  39 35 33 34
Obesity (≥30 kg/m2, %) 14 9 9 11
Total cholesterol (mmol/L)a 5.4 (1.1) 5.2 (1) 5.3 (1.1) 5.3 (1.1)
HDL cholesterol (mmol/L)a 1.3 (0.4) 1.4 (0.4) 1.4 (0.4) 1.4 (0.4)
Glucose (mmol/L)a 5.4 (1.5) 5.2 (1.2) 5.2 (1.3) 5.3 (1.5)
Systolic blood pressure (mm Hg)a 123 (17) 121 (16) 120 (16) 120 (16)
Hypertension (%)e 23 18 17 18
Self-reported CVD risk factor medication (%)f 7 5 5 6
Diabetes mellitus type 2 (%) 1.4 0.6 0.8 1.4
cardiovascular events
Non-fatal CVD (n/%)g 309/9.2 531/6.5 456/6.3 97/6.7
Non-fatal CHD (n/%)h 209/6.2 345/4.3 260/3.6 51/3.5
Fatal CVD (n/%)g 42/1.2 58/0.7 64/0.9 13/0.9
Fatal CHD (n/%)h 25/0.7 25/0.3 33/0.5 5/0.3
a Numbers are given as mean (SD); b Numbers are based on baseline data from 1994–1997; c Moderate 
alcohol consumption: ≤2 glasses per day for men and ≤1 glass for women; d Numbers are based on baseline 
data from 1993 and 1994; e Systolic blood pressure ≥ mm Hg and/ or diastolic blood pressure ≥90 mm Hg 
and/or usage of antihypertensive medication; f Cholesterol lowering and/or antihypertensive medication; 
g CVD were defined according to ICD-9 codes 410–414, 415.1,427.5, 428, 430–438, 440–444, 798.1, 798.2 
and 798.9 and corresponding ICD-10 codes for the fatal cases after 1996; h CHD was defined according to 
ICD-9 codes 410–414 and corresponding ICD-10 codes for the fatal cases after 1996.
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The exclusion of participants with a CVD event during the first 2 years of follow-up did not 
attenuate our results; neither did exclusion of participants with prevalent type 2 diabetes, with 
underweight, or those with CVD risk factor medication.
dIscussIon
For short sleepers, we observed a 15% higher risk of total CVD and a 23% higher risk of CHD 
compared to normal sleepers after adjustment for relevant confounders. These associations 
could partially be explained by intermediate biological risk factors. Compared to participants 
with a normal sleep duration and good sleep quality, those with both short sleep duration and 
poor sleep quality had a 63% higher risk of total CVD incidence and a 79% higher risk of CHD 
incidence. Long sleepers did not have an increased risk of total CVD or CHD incidence. 
The finding that short sleep duration was associated with increased total CVD2,13-19 and 
CHD incidence1,2,13,15,16,18,20,21 has previously been reported. Epidemiological studies showed 
that short sleep duration was associated with higher incidence of overweight, obesity, and 
hypertension, with higher levels of blood pressure, total cholesterol, hemoglobin A (1c), and 
table 5.2 hazard ratios (95% cI) of incident total cVd and chd by sleep duration category; the 
MorGen study, 1993–1997 
 Sleep duration
 ≤6 h 7 h 8 h ≥9 h
Persons at risk, n 3,387 8,216 7,349 1,480
Incident total CVD, n 331 563 488 104
Person years 39,738 97,980 87,967 17,468
Model 1a 1.25 (1.09–1.43) 1.00 (ref) 0.99 (0.88–1.12) 1.04 (0.84–1.28)
Model 2b 1.20 (1.05–1.37) 1.00 (ref) 0.98 (0.87–1.11) 1.00 (0.81–1.23)
Model 3c 1.15 (1.00–1.32) 1.00 (ref) 0.97 (0.86–1.10) 0.94 (0.76–1.16)
Model 4d 1.11 (0.97–1.27) 1.00 (ref) 0.95 (0.84–1.08) 0.96 (0.77–1.18)
Incident CHD, n 227 361 280 55
Person years 40,185 98,969 88,929 17,715
Model 1a 1.33 (1.13–1.57) 1.00 (ref) 0.89 (0.76–1.04) 0.85 (0.64–1.14)
Model 2b 1.29 (1.09–1.53) 1.00 (ref) 0.88 (0.75–1.03) 0.82 (0.61–1.09)
Model 3c 1.23 (1.04–1.45) 1.00 (ref) 0.87 (0.74–1.02) 0.77 (0.58–1.02)
Model 4d 1.19 (1.00–1.40) 1.00 (ref) 0.85 (0.73–1.00) 0.78 (0.58–1.04)
a Model 1: analyses adjusted for age and sex; 
b Model 2: model 1 + smoking, alcohol, and coffee;
c Model 3: model 2 + subjective health and educational level; 
d Model 4: model 3 + BMI, total-/HDL cholesterol ratio, systolic blood pressure, CVD risk factor medication, 
and prevalence of type 2 diabetes.
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Figure 5.1 hazard ratios (95% cI) of incident cVd (a) and chd (b) by sleep duration and sleep 
quality, adjusted for age, sex, smoking, alcohol, coffee, subjective health and educational level; the 
MorGen study, 1993 and 1994. 
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triglycerides.2-4 Also, blood pressure declines to its lowest levels during nighttime sleep when 
the parasympathetic activity is highest.22 Consequently, the arteries of people with short sleep 
duration benefit the least from this positive effect. Indeed, part of the association was explained 
by adjusting for BMI, total-/HDL cholesterol ratio, systolic blood pressure, and prevalence of 
type 2 diabetes. Unfortunately, we were unable to assess the effects of hemoglobin A (1c), 
triglycerides, or nocturnal blood pressures on our results.
In our study, long sleep duration was not associated with CVD and tended to be protective 
for CHD (HR: 0.77; 95% CI: 0.58–1.02). The latter result was not observed in earlier research. 
Cappuccio et al. reported in their meta-analysis of long compared to normal sleep duration, 
a RR of 1.41 (95% CI: 1.19–1.68) for total CVD and 1.38 (95% CI: 1.15–1.66) for CHD.1 However, 
our trend towards a protective association between long sleep duration and CVD is consistent 
with the results of King et al., who observed that the longer the (actigraphically measured) sleep 
duration, the lower the 5-year incidence of coronary artery calcifications.23  
We observed that short sleepers did not have a higher risk of CVD or CHD incidence compared 
to normal sleepers when both had good sleep quality. Only short sleepers with poor sleep 
quality had a 63% higher risk of CVD and a 79% higher risk of CHD. When looking within short 
sleepers only, poor compared to good sleep quality increased the risk of CHD. The results also 
suggest an increased risk of total CVD, but this association did not reach statistical significance. 
This is consistent with our findings presented in Figure 5.1. In line with our results, Chandola 
et al. observed in the Whitehall II cohort that the association of short sleep (≤6 h) with CHD 
risk was greatest among those who reported some sleep disturbance.6 These findings support 
the hypothesis that for some people, sleep duration of 6 hours or less may be adequate for the 
restorative physiologic processes accompanied by sleep, but not for others.6 Therefore, sleep 
quality should be taken into account in addition to sleep duration when investigating sleep. 
We obtained data on non-fatal CVD and CHD incidence through linkage with the Dutch Hospital 
Discharge Diagnosis Database (HDR). In a validation study, with an approximate 33% overlap 
of participants from our study, the HDR was compared with the detailed clinical registry of 
cardiovascular patients of the Cardiology department of Maastricht University Hospital.24 A 
high sensitivity (84%) and positive predictive value (97%) were observed for CHD hospital 
admissions.24 Causes of death were obtained through linkage with “Statistics Netherlands” in 
the present study. In a study in which causes of death were coded again 2 years after initial 
coding, agreement ranged from 77% to 89% for cardiovascular diseases.25 If non-fatal or fatal 
CVD or CHD cases in our study have been missed, this is unlikely to be related to sleep duration 
and will therefore not have biased our results.
Our results must be considered in the context of the inherent limitations of research on sleep 
duration. As in most other epidemiological studies, a self-reported single survey item was 
used to assess sleep duration and sleep quality. It was not feasible to obtain more detailed and 
objective measures of sleep, such as actigraphic or polysomnographic measures, from such a large 
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population.6 Reported sleep durations may represent time spent in bed rather than physiologic 
sleep duration.26 Lauderdale et al. observed that actigraphically measured sleep duration was 
shorter than self-reported questionnaire sleep duration (6.06 h vs. 6.65 h on a weekday).27 This 
measurement error may have biased our results since it is related to age, sex, and subjective 
sleep quality.28 Sleep quality was assessed in the first two years of the study. The question on 
sleep quality was dropped due to space limitations when in the third year additional questions on 
other topics were added to the questionnaire. Since sample selection has not changed over the 
years, it is unlikely that this group is different from the people measured in subsequent years. We 
therefore do not suspect any selection bias. Sleep quality was assessed as rising rested which is 
an indirect measure of sleep quality. As in other studies assessing sleep quality by questionnaire, 
this question was not validated. However, those not rising rested are likely to have poor sleep 
quality, even detecting people with micro-arousals or disturbances in sleep phases who might 
not even know they have poor sleep quality. These people only experience not rising rested in 
the morning. Moreover, we did not have the power to analyze the “don’t know” category of the 
rising rested question separately. Therefore, we excluded those answering “don’t know” from our 
analyses pertaining to sleep quality. Finally, data on physical activity, which could be an important 
confounder, were available for only 77% of the participants. Multivariate analyses with and without 
adjustment for physical activity yielded similar risk estimates for sleep duration and CVD incidence. 
Therefore, residual confounding by physical activity is not a major issue in the present study. 
A major strength of the present study was the comprehensive data collection from a large study 
population that allowed us to adjust for a large number of potential confounders. Another 
advantage was that we could investigate intermediate risk factors and explore the interaction 
of sleep duration with sleep quality in relation to CVD and CHD incidence. 
In conclusion, we observed that short sleep duration was associated with total CVD and CHD 
incidence, whereas long sleep duration was not. This association could partially be explained by 
intermediate biological CVD risk factors. The strongest association with CVD and CHD incidence 
was found in short sleepers with poor sleep quality. Future investigations should not only focus 
on sleep duration, but should also take sleep quality into account.
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AbstrAct 
Background: The contribution of sufficient sleep duration to lower CVD risk in addition 
to sufficient physical activity, a healthy diet, moderate alcohol consumption, and non-
smoking has not been investigated yet. 
Design: The MORGEN Study is a prospective cohort study including 8,128 men and 9,759 
women aged 20–65 years, free of CVD at baseline. 
Methods: Sufficient physical activity (≥3.5 hrs/wk cycling or sports), a healthy diet 
(Mediterranean Diet Score ≥5), moderate alcohol consumption (≥1 beverage/month), 
non-smoking, and sufficient sleep duration (≥7 hours) were assessed by self-administered 
questionnaires between 1994 and 1997. Cardiovascular morbidity and mortality were 
ascertained through linkage with national registers. Hazard ratios (HRs) and preventable 
proportions were calculated adjusted for age, sex, and educational level. 
Results: During 10 to 14 years of follow-up, 607 composite CVD events (fatal CVD, nonfatal 
myocardial infarction and stroke) occurred, of which 129 were fatal. Those with the four 
traditional healthy lifestyle factors had a 57% lower risk of composite CVD (HR: 0.43 [95% 
CI: 0.31–0.59]) and a 67% lower risk of fatal CVD (HR: 0.33 [0.16–0.68]) compared with 
those with none or one healthy lifestyle factor. Sleeping sufficiently in addition to the 
four traditional lifestyle factors resulted in a 65% lower risk of composite CVD (HR: 0.35 
[0.23–0.52]), and an 83% lower risk of fatal CVD (HR: 0.17 [0.07–0.43]). 
Conclusions: Sufficient sleep and adherence to all four traditional healthy lifestyle factors 
was associated with lower CVD risk. When sufficient sleep duration was added to the 
traditional lifestyle factors, the risk of CVD was further reduced. 
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IntroductIon 
Physical activity,1,2 diet,3,4 alcohol consumption,5,6 and smoking7-9 have all been individually 
associated with incident cardiovascular diseases (CVD). Since these lifestyle factors tend to cluster 
in individuals,10 different combinations of these factors in relation to incident CVD have been 
investigated.11-21 When investigating scores of healthy lifestyle factors, the highest compared 
with the lowest adherence to a healthy lifestyle was associated with hazard ratios (HRs) ranging 
from 0.24 to 0.35 for fatal CVD.11-14,17-19 Similarly, these HRs ranged from 3.12 to 8.17 for scores 
representative of unhealthy lifestyle factors.15,16 
Most studies investigating combinations of lifestyle factors have included physical activity, diet 
or dietary components, alcohol consumption, smoking and body mass index (BMI) or waist 
circumference.11,12,14-18,21-25 Recently, it has been shown that poor sleep duration is an independent 
risk factor for CVD.26,27 So far, only two studies have included sleep duration as a lifestyle factor.11,17 
Both studies were performed in Asian populations and assessed the combination of all lifestyle 
factors with CVD, without providing insight into the additional impact of sleep outside of the 
other healthy lifestyle factors. 
The purpose of the present study was to examine whether sufficient sleep duration, in addition 
to sufficient physical activity, a healthy diet, moderate alcohol consumption, and non-smoking, 
further reduces CVD incidence.
Methods
study population
The Monitoring Project on Risk Factors for Chronic Diseases (MORGEN Study) was carried out 
in the Netherlands between 1993 and 1997 with 10,448 men and 12,652 women. Municipal 
population registers were used as sampling frames to draw random sex- and age-stratified 
samples in three cities in the Netherlands (Doetinchem, Maastricht, and Amsterdam). The 
response rate in the MORGEN Study was 45%.28 
We excluded participants examined in 1993 due to the use of a different physical activity 
questionnaire (n=5,213), persons with prevalent CVD or type 2 diabetes based on self-report and 
hospital discharge data (n=613), women who were pregnant at baseline (n=115), persons with 
extremely low or high reported energy intakes (i.e., those in the lowest and highest 0.5% of the 
ratio of energy intake over basal metabolic rate) (n=166) and those with no information on one 
or more of the lifestyle factors or covariates (n=683), as well as those with no information on vital 
status or cardiovascular events (n=1,671). After these exclusions, 6,672 men and 7,967 women 
remained for our analyses. There was no meaningful difference in age and sex between those 
included and those excluded; however, those excluded had a slightly lower educational level. 
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Lifestyle
Physical activity
Physical activity was assessed with a validated questionnaire29 developed for the “European 
Prospective Investigation into Cancer and Nutrition” (EPIC). Cycling was assessed according 
to the number of hours spent per week, separately for summer and winter, and the average 
number of hours was included in our analyses. For the MORGEN Study, the EPIC questionnaire 
was extended with two open-ended questions on type, frequency, and duration of sports per 
week. The recommendation in the Netherlands is 30 minutes of moderate to vigorous physical 
activity per day for 5 to 7 days a week.30 Therefore, spending 3.5 hours or more per week on 
cycling plus sports (≥4 MET) was considered sufficient physical activity and less than 3.5 hours 
per week, insufficient physical activity.
Diet
Dietary intake was assessed with a validated food frequency questionnaire,31,32 including 
questions on the habitual frequency of consumption of 178 food items during the year preceding 
enrollment. Additional information was obtained regarding the frequency of consumption of 
different sub-items and the preparation methods. Colored photographs were used to estimate 
portion sizes of 28 food items.31,32 We operationalized the concept of a healthy diet with the 
modified Mediterranean Diet Score (MDS) defined by Trichopoulou et al.33 For the composition 
of this score, values of 0 or 1 were assigned to each nutritional component. For vegetables, 
fruits, legumes and nuts, grains, fish and seafood, and the ratio of unsaturated to saturated fatty 
acids, intakes equal to or above the sex-specific median were assigned a value of 1, and intakes 
below that median a value of 0. As the traditional Mediterranean diet is characterized by a low 
intake of meat and dairy products, the scoring of these products was inverted. The MDS could 
result in a value from 0 (minimal adherence) to 8 (maximal adherence). We classified an MDS 
of 5 or higher as a healthy diet and the remainder as an unhealthy diet.
Alcohol consumption 
Alcohol consumption was also assessed with the food frequency questionnaire32 and 
dichotomized in non-consumption (<1 glass per month) and moderate consumption (≥1 
glass per month). Because of the relatively low level of alcohol consumption in the MORGEN 
population, consumption of alcohol was considered moderate and therefore a healthy lifestyle 
factor for CVD. Of the total population, 23% consumed more than two glasses of alcohol per 
day. Although we did not define an upper limit for alcohol consumption, this is, of course, 
necessary in establishing public health guidelines.21 
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Smoking
Information on smoking was obtained by a self-administered questionnaire.28 Since CVD risk 
swiftly declines after smoking cessation, never or past smoking (non-smoking) was classified 
as a healthy lifestyle factor and current smoking as an unhealthy lifestyle factor.
Sleep duration
Information on sleep duration was obtained by a self-administered questionnaire. The usual 
sleep duration was assessed by the question “How many hours of sleep do you usually get per 
24-hour period?”. We showed in a previous study that short (≤6 hours) compared with normal 
(7–8 hours) sleep duration increased CVD risk, whereas long (≥9 hours) sleep duration did not.26 
Therefore, we classified sleep duration of ≥7 hours as sufficient and the remainder as insufficient.
Ascertainment of fatal and nonfatal cVd events
Participants were followed to the first nonfatal cardiovascular event, death, or emigration or were 
censored at January 1, 2008. Morbidity data were provided by the National Medical Register (NMR) 
with the Dutch Hospital Discharge data. Eighty-eight percent of the hospital admissions can be 
linked uniquely to an individual on the basis of sex, date of birth, and postal code.34 We obtained 
vital status through linkage with municipal population registers. Subsequently, primary and 
secondary causes of death were obtained through linkage with data from ‘Statistics Netherlands’.28 
Composite CVD was defined as fatal CVD (ICD935 codes 390–459 and 798), plus nonfatal 
myocardial infarction (410–412 and 414) and stroke (430–434, and 436). Causes of death after 
1996 were coded according to the corresponding ICD1036 codes. For nonfatal myocardial 
infarction and stroke, only first events were taken into account. For fatal CVD, no exclusions 
were made because of previous nonfatal events. 
covariates
Information on age, sex and the highest educational level achieved was obtained by question-
naire.28 Educational level was classified as low (lower vocational training or primary school), 
medium (secondary school and intermediate vocational training), or high (higher vocational 
training or university). To calculate BMI, weight was measured to the nearest 0.1 kg and height 
to the nearest 0.5 cm.28 Non-fasting plasma total cholesterol and high density lipoprotein (HDL) 
cholesterol were determined in the Lipid Reference Laboratory of the University Hospital Dijkzigt 
in Rotterdam by standardized enzymatic methods.28 Systolic blood pressure was recorded twice 
with a Random Zero Sphygmomano-meter at the appearance of sounds (first-phase Korotkoff) 
in sitting position.28 The average of the two blood pressure measurements was included in 
current analyses.
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statistical analyses
Statistical analyses were performed with SAS 9.3 software (SAS Institute, Inc., Cary, NC). 
Participants’ characteristics are presented as means (standard deviation) for continuous variables 
and as percentages (total number) for categorical variables. We used Cox proportional hazards 
models to estimate HRs and 95% confidence intervals (CI) for (combinations of) lifestyle factors 
in relation to composite and fatal CVD. We assessed these associations in categories with 
none or one healthy lifestyle factor as the reference category and continuously per healthy 
lifestyle factor. We assessed interaction on a multiplicative scale for age, sex, educational level 
and BMI with the number of healthy lifestyle factors in relation to composite and fatal CVD at 
p<0.10. The proportional hazard assumption was fulfilled according to the graphical approach 
and according to Schoenfeld residuals. We performed our analyses separately for the four 
traditional lifestyle factors (five-point score: 0–4) and for the traditional lifestyle factors plus 
sleep duration (six-point score: 0–5). In order to compare the six-point score to the five-point 
score, the six-point score was recalculated to the five-point score by multiplying the logarithm 
of the estimated HRs by 6/5 before exponentiating them. To estimate the proportion of cases 
that could theoretically be prevented or postponed by adherence to a healthier lifestyle, we 
calculated the preventable proportion with the equation developed by Wahrendorf.37 All 
analyses shown in the tables were adjusted for age, sex and highest educational level achieved. 
In a sensitivity analysis, we additionally adjusted the analyses for systolic blood pressure, BMI, 
and the ratio of serum total cholesterol to HDL cholesterol. In another sensitivity analysis, 
CVD cases in the first two years of follow-up were excluded. A p-value of 0.05 was considered 
statistically significant.
resuLts
During 10 to 14 years of follow-up (mean, 12 years), 607 composite CVD events occurred, 
of which 129 were fatal. table 6.1 shows the distribution of participants’ characteristics at 
baseline and CVD incidence stratified by sex. Participants were on average 42 years of age at 
baseline, and 46% were male. Men were slightly better educated than women. Of the total 
population, 52% were sufficiently physically active, and 37% consumed a healthy diet. Among 
men, 91% consumed alcohol, compared with 78% of women. About 65% of the population 
were non-smokers, and 80% of the men and 86% of the women slept a sufficient number of 
hours. The distribution of the number of healthy lifestyle factors was similar for both men and 
women. Of the total population, 6% adhered to none or one healthy lifestyle factor, and 12% 
adhered to all five healthy lifestyle factors.
table 6.2 shows the associations of the single lifestyle factors with composite and fatal CVD 
after adjustment for age, sex, educational level, and with and without mutual adjustments for the 
other lifestyle factors. With mutual adjustments, non-smoking was strongly inversely associated 
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with composite CVD (HR: 0.57 [0.48–0.67]), as were sufficient sleep duration (HR: 0.78 [0.65–0.94]) 
and moderate alcohol consumption (HR: 0.79 [0.63–0.98]). Non-smoking (HR: 0.61 [0.43–0.86]) 
and sufficient sleep duration (HR: 0.57 [0.39–0.83]) were both strongly inversely associated with 
fatal CVD. For sufficient physical activity, a healthy diet, and moderate alcohol consumption the 
associations with composite and fatal CVD were all inverse, although mostly not statistically 
significant. Without mutual adjustments, most associations were slightly stronger, especially 
for diet and physical activity.
The association between the number of healthy lifestyle factors and composite and fatal CVD 
was non-linear, with the largest decrease in risk for two healthy lifestyle factors compared to 
table 6.1 Participants’ characteristics at baseline and cVd incidence by sex, MorGen study 
1994–1997a
 Men
n=6,672
Women
n=7,967
Age (years, mean, [sd]) 42 (11) 41 (11)
Educational level
Low 42 (2,777) 51 (4,039) 
Medium 31 (2,038) 27 (2,159)
High 28 (1,857) 22 (1,769) 
Sufficient physical activityb 52 (3,436) 53 (4,222) 
Healthy dietc 37 (2,489) 37 (2,986) 
Alcohol consumptiond 91 (6,068) 78 (6,182)
Intake among consumers (median [q1–q3])e 14 (6–28) 6 (2–14)
Non-smokingf 66 (4,379)  65 (5,172) 
Sufficient sleep durationg  80 (5,346) 86 (6,880) 
Number of healthy lifestyle factorsh   
0–1 5 (331) 6 (472)
2 19 (1,272) 20 (1,623) 
3 33 (2,174) 33 (2,685) 
4 32 (2,129) 29 (2,271) 
5 11 (766) 12 (943) 
Composite CVDi 6 (384) 3 (223) 
Fatal CVD 1.3 (87) 0.5 (42) 
aAll data are shown as ‘% (n)’ unless otherwise indicated; b Sufficient physical activity was defined as ≥3.5 
hrs/wk cycling and sports; c A healthy diet was defined as a Mediterranean Diet Score of 5–8 (range 0–8); 
d Alcohol consumption was defined as ≥ one glass per month; e Grams/ day; f Non-smoking was defined 
as never or past smoking; g Sufficient sleep duration was defined as ≥7 hrs; h Sufficient physical activity, a 
healthy diet, moderate alcohol consumption, non-smoking, and sufficient sleep duration; i Composite of 
fatal CVD plus nonfatal myocardial infarction and stroke.
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none or one (table 6.3). Adherence to all four traditional healthy lifestyle factors was associated 
with a 57% lower risk of composite CVD (HR: 0.43 [0.31–0.59]), and a 67% lower risk of fatal 
CVD (HR: 0.33 [0.16–0.68]) compared with adherence to none or one. After addition of sufficient 
sleep duration to adherence to all four traditional healthy lifestyle factors – thus comparing five 
to none or one healthy lifestyle factor – the CVD risk was even lower: HR: 0.35 (0.23–0.52) for 
composite CVD and HR: 0.17 (0.07–0.43) for fatal CVD. The preventable proportions showed 
that, if all participants adopted all four traditional healthy lifestyle factors, 36% of the composite 
CVD cases and 46% of the fatal CVD cases could theoretically be prevented or postponed. The 
percentage of composite CVD cases that would theoretically be prevented or postponed by 
adherence to all five lifestyle factors remained 36%. However, for fatal CVD, this percentage 
increased from 46% to 57%.
There were no statistically significant interactions for age, sex, educational level, and BMI in any 
of the associations. Exclusion of the first two years of follow-up slightly attenuated the results.
table 6.2 hazard ratios (95% cI) of lifestyle factors for composite and fatal cVd, MorGen study 
1994–1997
 Composite CVD
n=607
Fatal CVD
n=129
 Model 1a Model 2b Model 1a Model 2b
Physical activityc
Insufficient 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Sufficient 0.80 (0.68–0.94) 0.87 (0.74–1.03) 0.67(0.47–0.95) 0.74 (0.52–1.06)
Dietd
Unhealthy 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Healthy 0.84 (0.71–1.00) 0.88 (0.74–1.05) 0.68 (0.46–1.01) 0.73 (0.50–1.08)
Alcohol consumptione
No 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Yes 0.81 (0.65–1.00) 0.79 (0.63–0.98) 0.70 (0.44–1.10) 0.70 (0.44–1.10)
Smokingf
Yes 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
No 0.56 (0.48–0.66) 0.57 (0.48–0.67) 0.57 (0.40–0.82) 0.61 (0.43–0.86)
Sleep durationg
Insufficient 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Sufficient 0.76 (0.63–0.91) 0.78 (0.65–0.94) 0.55 (0.38–0.80) 0.57 (0.39–0.83)
a Model 1: Adjusted for age, sex, educational level; b Model 2: model 1 plus mutually adjusted for the other 
lifestyle factors; c Sufficient physical activity was defined as ≥3.5 hrs/wk cycling and sports; d A healthy diet 
was defined as a Mediterranean Diet Score of 5–8 (range 0–8); e Alcohol consumption was defined as ≥ 
one glass per month; f Non-smoking was defined as never or past smoking; g Sufficient sleep duration was 
defined as ≥7 hrs.
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dIscussIon
In this study, the combination of sufficient physical activity, a healthy diet, moderate alcohol 
consumption, and non-smoking was associated with a 57% lower risk of composite CVD and a 
67% lower risk of fatal CVD compared with adherence to none or one of these healthy lifestyle 
factors. The addition of sufficient sleep to adherence to all four traditional healthy lifestyle 
factors resulted in a 65% lower risk of composite CVD and an 83% lower risk of fatal CVD. If 
all participants adhered to all five healthy lifestyle factors, 36% of composite CVD and 57% of 
fatal CVD could theoretically be prevented or postponed.
Some limitations of the study need to be addressed. All lifestyle factors were self-reported. 
We have no data on the reproducibility and validity of sleep duration. It was not feasible to 
obtain more detailed and objective measures of sleep, such as actigraphic or polysomnographic 
measures, from such a large population.38 Self-reported sleep durations may represent time 
spent in bed rather than physiologic sleep duration. Lauderdale et al. observed that actigraphic-
measured sleep duration was about 10% shorter than self-reported sleep duration.39 This 
measurement error may have biased our results, since it is related to age, and sex.40 Median 
reproducibility for physical activity,29 dietary intake,31,32 and alcohol consumption32 ranged from 
0.5 for cycling to 0.9 for alcohol consumption, and median relative validity ranged from 0.5 for 
cycling and food groups to 0.8 for alcohol consumption. All lifestyle factors were assessed only 
once and may have changed during follow-up, resulting in non-differential misclassification 
that may have attenuated our associations.
Our study has several strengths. The MORGEN Study is a large, prospective cohort study that 
includes both men and women from the general population, with a broad age range and a long 
follow-up period. We are the first to investigate whether the addition of sleep duration to the 
four traditional healthy lifestyle factors contributed to an association with CVD.
Cardiovascular follow-up was obtained by linkage to several national registers. In a validation 
study conducted in a subsample of this population, a high sensitivity was observed for acute 
myocardial infarction hospital admissions (84%) comparing the Dutch Hospital Discharge 
data with that of a detailed clinical register.41 In a study in which causes of death were coded 
again two years after initial coding, the agreement was 89% for myocardial infarction, 79% for 
stroke and 92% for total CVD.42 Despite the relatively high level of agreement, non-differential 
misclassification of cardiovascular morbidity and mortality may have attenuated our results.
Comparison with the results of other studies was hampered by differences between studies in 
definition and operationalisation of lifestyle factors and CVD events. For instance, we did not 
include BMI or waist circumference as a lifestyle factor, because we considered those to be 
outcomes of lifestyle factors and intermediates in the association between lifestyle factors and 
CVD. In this study, the highest level of adherence to the four traditional lifestyle factors compared 
with the lowest was associated with a 57% lower risk of composite CVD. When Stampfer et al.21 
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compared five healthy lifestyle factors (non-smoking, sufficient physical activity, desirable BMI, 
moderate alcohol consumption, healthy diet) with none or one, they observed a 75% lower 
risk of a composite of CVD. We observed a 67% lower risk for fatal CVD when comparing the 
highest to the lowest adherence to the four traditional lifestyle factors which is comparable 
to the 65–76% lower risk in other investigations.12-14,18,19 Despite differences between studies, 
adherence to the four traditional healthy lifestyle factors was consistently associated with a 
lower CVD risk of at least 50%.
We observed that sufficient sleep duration was independently and strongly associated with 
a lower risk of composite CVD and an even lower risk of fatal CVD. Additional adjustments 
for the intermediate factors systolic blood pressure, BMI and the ratio of serum total to HDL 
cholesterol slightly attenuated the associations. In a recent meta-analysis by Cappuccio et al. 
that incorporated 15 cohort studies, short sleep duration was associated with a greater risk of 
fatal and non-fatal coronary heart disease (RR: 1.48 [1.22–1.80]), and stroke (RR: 1.15 [1.00–1.31]), 
but not total CVD (HR: 1.03 [0.93–1.15]).27 Short sleep duration has also been associated with 
a higher incidence of overweight, obesity and hypertension and with higher levels of blood 
pressure, total cholesterol, hemoglobin A (1c) and triglycerides.43 Mechanisms include changes 
in circulating levels of leptin and ghrelin that, in turn, increase appetite, caloric intake, reduce 
energy expenditure and facilitate the development of obesity and impaired glycemic control.44 
Also, low-grade inflammation is activated as a result of short sleep duration.44 Although we 
cannot exclude depressive symptoms, sleep apnea or psychological stress as partial explanations 
for the observed associations,45 the mechanisms are consistent with the hypothesis that short 
sleep duration is directly associated with CVD risk.  
In conclusion, sufficient sleep duration was independently associated with both composite and 
fatal CVD. Also, the combination of sufficient physical activity, a healthy diet, moderate alcohol 
consumption and non-smoking was associated with a substantially lower risk of composite and 
fatal CVD. Although the risk was low in persons adhering to the four traditional healthy lifestyle 
factors, the addition of sufficient sleep duration to these factors further reduced CVD risk. Our 
results suggest that the addition of sufficient sleep duration to the traditional lifestyle factors 
increases the percentage of fatal CVD cases that could be prevented or postponed from 46% 
to 57%. If replicated in other studies, the public-health impact of sufficient sleep duration, in 
addition to the traditional healthy lifestyle factors, could be substantial.
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The focus of the research described in this thesis was on the Mediterranean style diet, aspects 
of leisure time physical activity and sleep in relation to CVD in the general population. The 
associations of these three lifestyle factors with CVD incidence were studied for each factor 
separately, and also in combination with smoking and alcohol consumption. In this chapter, we 
discuss the main findings (Table 7.1), some methodological considerations and the effects of 
these lifestyle factors on CVD risk factors in intervention studies. We conclude with a discussion 
of the potential public health implications of the associations of these lifestyle factors with CVD.
MediTerranean sTyle dieT
Main findings for a Mediterranean style diet and CVd risk
•	 The Mediterranean Diet Score (MDS) was more strongly inversely associated with fatal CVD 
than with total CVD. 
•	 The MDS was inversely related to incident myocardial infarction, stroke and pulmonary 
embolism.
•	 The use of multiple measurements of the MDS increased the strength of the inverse 
associations with composite and fatal CVD and narrowed the confidence intervals of the 
estimated HRs.
interpretation of the Mediterranean diet score in the northern 
european context
In this thesis, we used the modified MDS defined by Trichopoulou et al. to operationalise a healthy 
dietary pattern.1 In this score, values of 0 or 1 were assigned to vegetables, fruits, legumes and 
nuts combined, grains, fish and seafood combined, the ratio of unsaturated to saturated fatty 
acids, meat and dairy based on sex-specific medians as cut-off points. Alcohol consumption 
was dichotomized into non-users (<1 drink/ month) and users. The MDS can take a value from 
0 (minimal adherence) to 9 (maximal adherence).1 
Some of the components of the MDS1 may not be optimally defined to quantify a healthy diet. 
For instance, within the MDS no distinction is made between whole grains and refined grains. 
With regards to fish and seafood, no differentiation is made between fatty fish and lean fish. 
For meat and milk products no distinction is made between low, medium or high saturated fat 
content. This shows that the MDS is a relatively crude indicator of a healthy dietary pattern.
In the traditional Mediterranean diet, alcohol was consumed in moderate amounts with meals. 
Trichopoulou, defined a ‘moderate’ amount as 5–25 gram alcohol per day for women and 
10–50 gram per day for men.1 In the MORGEN population, only 8% of women and 7% of men 
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consumed more than this amount. We observed in the MORGEN Study a lower CVD risk for 
all alcohol users compared to non-users (results not shown) which is compatable to literature.2 
Therefore, we dichotomized alcohol consumption into non-users (<1 drink/ month) and users. 
A high score on the MDS in our study population, may not necessarily represent a high adherence 
to the traditional Mediterranean diet. As described above, the scoring system is based on levels 
of intake of broad food groups that are dichotomized into a low or high level of consumption 
based on population specific medians. In The Netherlands, as in other Northern European 
countries, olive oil, vegetables, fruits, legumes, nuts, are less frequently consumed than in the 
traditional Mediterranean diet.2 Hence, in the Dutch population even the highest adherence to 
the MDS, does not resemble the traditional Mediterranean diet.2
In addition to the difference in population specific medians, also the content of the general 
food groups in Northern European countries differs from that of the traditional Mediterranean 
diet. For instance, in the Mediterranean, almonds are usually eaten,3 whereas in our population 
mainly peanuts were consumed. Because both legumes and nuts are consumed in relatively 
small quantities in Northern European populations, Trichopoulou combined legumes and nuts 
into one category.1 However, legumes and nuts differ in beneficial properties. For instance, 
nuts are a rich source of polyunsaturated fatty acids whereas legumes are not. Furthermore, 
olive oil consumption is low in non-Mediterranean populations. Therefore, olive oil was 
replaced by the ratio of unsaturated to saturated fatty acids in the MDS of Trichopoulou.1 
Plant oils used in Northern Europe, such as sunflower oil are high in polyunsaturated fatty 
acids and olive oil are rich in monounsaturated fatty acids. Both oils are characterized by a 
high unsaturated to saturated fatty acid ratio. The effects of monounsaturated fatty acids 
on blood lipids hardly differ from those of polyunsaturated fatty acids.4,5 Therefore, the ratio 
of unsaturated to saturated fatty acids can be used for both Mediterranean and Northern 
European populations.
In conclusion, in the present study diet was operationalized with a relatively crude dietary pattern 
score. The food groups included in the MDS consist of different foods, and are eaten in different 
quantities in both Northern European and Mediterranean countries. Despite these differences 
between the traditional Mediterranean and a Northern European diet, the ranking of people 
based on the basic foods in Non-Mediterranean countries are likely to be valid since observed 
health benefits are similar in Mediterranean as in non-Mediterranean countries.6 This suggests 
that the health-enhancing properties of what has been labeled the Mediterranean diet is not 
necessarily based on Mediterranean foods or on absolute intakes.3 Rather, the Mediterranean 
diet is a prototype of a healthy diet. 
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intervention studies of Mediterranean style diets on CVd risk factors 
and endpoints
The traditional Mediterranean diet has many beneficial properties. It has a high content of 
fibre,	n-3	fatty	acids,	and	antioxidants,	as	well	as	β-carotene,	vitamins	C	and	E,	and	polyphenols	
from olive oil, legumes, whole grains, fruits, and vegetables. Furthermore, the diet is low in 
trans fatty acids, saturated fatty acids, and high in monounsaturated fat, mainly from olive 
oil.7,8 A meta-analysis of randomized controlled trials showed that a Mediterranean diet was 
associated with favourable changes in systolic and diastolic blood pressure, fasting plasma 
glucose, total cholesterol, body weight, body mass index, and high-sensitivity C-reactive protein 
in comparison to low-fat diets.9 All these factors combined may be responsible for the low CVD 
risk in populations with a traditional Mediterranean diet. 
In the Lyon Diet Heart Study, a secondary prevention trial in 423 myocardial infarction patients, 
a Mediterranean style diet enriched with alpha-linolenic acid followed for 27 months reduced 
cardiac death and non-fatal myocardial infarction by 73% compared with a prudent diet.10,11 
After 48 months – 21 months after stopping the diet – the Mediterranean style diet group still 
had a lower risk of recurrent CVD compared to the group with the prudent diet.10 It should be 
noted that this study was stopped early for apparent benefit. This could have overestimated the 
protective effect of the Mediterranean diet. Therefore, other and larger intervention studies are 
needed before definitive statements can be made on the beneficial effect of a Mediterranean 
diet on CVD. 
PhysiCal aCTiViTy
Main findings for physical activity and CVd risk
•	 Cycling and sports were associated with a low CVD risk.
•	 For sports there was a dose-response relationship with CVD, but not for cycling.
•	 Those who both cycled and performed sports had the lowest CVD risk.
•	 Walking and gardening were not associated with CVD.
Methodological aspects of physical activity questionnaires
Leisure time physical activity was assessed with a validated12 questionnaire designed for the 
“European Prospective Investigation into Cancer and nutrition” (EPIC). For walking (to and from 
work and during leisure time), cycling (to and from work and during leisure time) and gardening 
the number of hours per week was assessed. For sports, the EPIC questionnaire was extended 
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in our study with two open-ended questions on type, frequency, and duration of sports, and 
one open-ended question on other strenuous activities. 
Physical activity questionnaires are commonly used in large cohort studies because of relatively low 
costs and low participant and researcher burden.13 However, an individual’s physical activity level 
may be misclassified based on questionnaire data due to social desirable answers by participants, 
recall bias14-16 and due to the lack of information on the intensity of the activities performed. 
Objective methods of physical activity measurement, such as doubly labeled water, accelerometry 
(e.g. actigraph) and combined heart rate monitoring (e.g. ActiHeart) do not have these sources of 
error and bias typical for subjective measurements such as activity diaries and questionnaires. The 
difference in sources of error and bias may also be reflected in the weaker associations observed 
for subjectively measured physical activity with CVD risk factors compared to objectively measured 
physical activity.17 However, objective measures do not distinguish different types and domains 
of physical activity and cannot cover usual activities over a longer period of time, in contrast to 
questionnaires. Furthermore, because of the costs, and relative burden on participants, objective 
measurements of physical activity are usually not feasible in large populations. Ideally, large cohort 
studies would complement subjective measurement methods of physical activity with an objective 
measurement method to estimate the intensities of the performed activities.
In this thesis, the associations of different types of activities with CVD incidence were based on 
a single measurement at baseline. Thus, changes in physical activity that may have occurred 
during follow-up were not taken into account. Such changes are likely, as was shown in the 
Doetinchem Cohort Study. Over a period of 10 years, 45% of the participants changed their level 
of physical activity, with equal numbers of people starting to adhere and stopping to adhere to 
the Dutch physical activity guideline.18 Since the Doetinchem cohort constitutes about one third 
of the MORGEN population, these results can probably be generalized to the entire MORGEN 
population. Misclassification of the activities during follow-up in our study may have resulted 
in an underestimation of the strength of the associations with CVD.
Another source of bias is the assignment of the intensities to different activities. As in other cohort 
studies, we chose conservative intensity levels from the Compendium of Physical Activities of 
Ainsworth.19 Intensities of activities can vary greatly. For instance, the intensity level of walking 
varies from 2.0 MET (walking, household) to 8.0 MET (walking, 5.0 mph) and of cycling from 
4.0 MET (<10 mph) to 16.0 MET (>20 mph). For individual sports there is a similar variance 
in intensity. Furthermore, assigned intensities depend on the version of the Compendium of 
Physical Activities. The compendium is updated about every ten years and with each update 
activities are added, and intensity levels are modified to reflect new information about the 
metabolic cost of specific activities.20 For instance, the intensity level of gardening (Ainsworth 
code 8245) was 4.0, 5.0 and 3.8 MET according to the Compendium of 1993, 2000 and 2011 
respectively. Thus, gardening was qualified as a moderate intense activity in 1993 and 2000, 
whereas in 2011 it was classified as a light intense activity. 
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To calculate whether persons adhere to the physical activity guidelines, it would have been 
useful to have information on the time spent on the different activities per day. In the EPIC 
questionnaire, the duration of the activities was assessed as the average number of hours per 
week. As a result, no distinction can be made between one bout of 3.5 hours of physical activity 
on one day and seven bouts of 0.5 hours on seven separate days. However, in studying etiologic 
associations, not the absolute level of physical activity is of primary interest, but the ranking 
of participants according to their level of physical activity. Our questionnaire was considered 
suitable for this purpose when validated against physical activity diaries,12 four-day heart rate 
monitoring,21 sub-maximum oxygen uptake,21 and against ActiHeart.13
The number of studies addressing sedentary behaviour as opposed to or in combination with 
physical activity is increasing.22 We did not investigate sedentary behaviour, as this was not 
included in the EPIC questionnaire. Sedentary behaviour is defined as any waking behaviour 
characterized	by	an	energy	expenditure	≤1.5	MET	while	in	a	sitting	or	reclining	posture.22 Studies 
with questionnaires on sedentary behaviour and physical activity suggest that those who were 
sedentary for many hours per day are at high risk of cardiovascular disease, regardless of their 
level of moderate to vigorous intensity physical activity.23-27 Because of the high frequency of 
sedentary behaviour in modern societies, research on the interaction of physical activities of at 
least moderate intensity with sedentary behaviour in the association with CVD, is of great interest. 
intervention studies of physical activity on CVd risk factors
In exercise intervention studies aerobic exercise was associated with favourable changes 
in systolic and diastolic blood pressure,28,29 HDL cholesterol,30 LDL-particle size,31 platelet 
aggregation and activation,32 insulin sensitivity in muscles,33,34 weight, and waist circumference.35 
All these factors combined may be responsible for the low CVD risk in populations with sufficient 
physical activity. 
Exercise intervention studies usually aim at CVD risk factors. Furthermore, the exercise is 
generally more intensive than habitual non-occupational physical activity and these studies do 
not examine the health benefits of daily life physical activities. Community intervention trials 
such as Hartslag Limburg,36 generally focus on moderate intense physical activity, and provide 
more information on attainable health benefits in a general population. Unfortunately, these 
interventions usually combine physical activity with other lifestyle factors so the independent 
effect of physical activity can not be determined. Intervention studies of low to moderate intense 
physical activities showed that walking had favourable effects on diastolic blood pressure, HDL- 
and LDL cholesterol, body weight, BMI, and percent body fat in previously sedentary adults.37,38 
For cycling, an increase in HDL cholesterol was observed, but no significant changes in total 
cholesterol or triglycerides.39 In conclusion, there is evidence for a positive effect of exercise on 
cardiovascular risk factors, though for the independent effects of low-moderate intense physical 
activities on hard CVD endpoints more research needs to be done.
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sleeP
Main findings for sleep and CVd risk
•	 Short sleep duration was associated with a higher risk of CVD compared to normal sleep 
duration.
•	 Long sleep duration was not associated with CVD risk. 
•	 Poor sleep quality was not associated with CVD risk.
•	 Short sleepers with poor sleep quality had the highest risk of CVD compared to those with 
a normal sleep duration and good sleep quality. 
Methodological aspects of sleep duration and sleep quality assessed 
by questionnaire
The average sleep duration was assessed by the question “How many hours of sleep do you 
usually get per 24 hour period?”, with answer categories ‘5 hours or less’, ‘6 hours’, ‘7 hours’, ‘8 
hours’, and ‘9 hours or more’. In our and many other cohort studies, self-reported sleep duration 
relied upon this single question. Lauderdale et al. observed that sleep duration was 10% shorter 
when objectively measured by actigraphy compared to self-reported by questionnaire.40 This 
disagreement between subjective and actigraphic measures of sleep duration was larger for 
older persons and men than for younger persons and women.41 Therefore, this measurement 
error may have biased our results.
We assessed sleep quality with the question “Do you usually feel rested when you rise?” from 
the Amsterdam Biographical Questionnaire on neuroticism.42 ‘Good sleep quality’ was defined 
if the answer was ‘yes’ for rising rested, and ‘poor sleep quality’ if the answer was ‘no’. As in 
other studies assessing sleep quality by questionnaire, this question was not validated. Rising 
rested is an indirect measure of sleep quality. People may not know that they have a poor sleep 
quality (for example because of micro-arousals or disturbances in sleep phases), but when they 
rise in the morning, they do not feel rested. Rising rested may therefore be a good proxy for 
sleep quality. 
The association between sleep and CVd risk factors
Sleep deprivation studies are used to study the effects of short sleep on intermediate CVD 
endpoints. In these studies, participants are exposed to very short sleep duration (usually around 
4 hours) for a short period of time. Sleep deprivation is not likely to have the same effects as 
‘habitual’ short sleep duration on CVD risk factors. Therefore, we discuss both the results from 
sleep deprivation studies and from prospective epidemiological studies in this section. 
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The relation between short sleep duration and CVD incidence could be due to an effect of 
short sleep on intermediate biological CVD risk factors such as BMI, hypertension, diabetes, 
hypercholesterolemia, and inflammatory markers.43-46 Short sleep duration is associated with 
overweight.47 The mechanisms supportive of the obesogenic effects of short sleep, as shown 
in sleep deprivation studies, include upregulation of appetite by reduced leptin and elevated 
ghrelin levels,48,49 lower energy expenditure, and altered glucose metabolism.50 Furthermore, 
longitudinal observational studies among healthy populations showed that short sleep duration 
was associated with a higher risk of hypertension.45,51 In a recent meta-analysis including 10 
cohort studies, a 28% higher risk of type 2 diabetes was observed among short sleepers 
compared to those with a normal sleep duration.44 Sleep plays an important role in the control 
of blood glucose levels, and recurrent partial sleep deprivation (four hours sleep per night) in 
11 young men had unfavourable effects on carbohydrate metabolism and endocrine function.52 
Short sleep duration was also associated with poor lipid profiles. Experimental sleep restriction 
(three nights of four hours) significantly increased total cholesterol and LDL cholesterol 
levels in postmenopausal women.53 In a longitudinal observational study, each additional 
hour of sleep was associated with a lower risk of a high blood cholesterol level in healthy 
young women, but not in men.46 Sleep deprivation could increase the risk of dyslipidemia by 
increasing appetite and dietary consumption of saturated fatty acids, decreasing motivation 
to engage in regular physical activity, and increasing stress resulting in catecholamine induced 
lipolysis.46 Finally, the CARDIA Study showed that each additional hour of (actigraphically 
measured) sleep duration was associated with a lower 5-year incidence of coronary artery 
calcifications.54 
Besides short sleep duration, also sleep quality may be important in relation to CVD risk. In 
a recent meta-analysis of 13 prospective studies including 122,500 participants, insomnia – 
defined as difficulty of initiating or maintaining sleep or presence of restless, disturbed nights 
– was associated with a 45% higher risk of fatal and non-fatal CVD.55 Artificial suppression of 
slow wave sleep (SWS) may resemble poor sleep quality. SWS, thought to be the most restorative 
sleep stage, is associated with a lower heart rate, lower blood pressure, lower sympathetic 
nervous activity and cerebral glucose utilization, compared with wakefulness.52 During SWS, 
growth hormone is released while the stress hormone cortisol is inhibited.52 In a trial in young 
healthy adults, all-night selective suppression of SWS, without any change in total sleep time, 
resulted in a marked decrease in insulin sensitivity without adequate compensatory increase 
in insulin release.56 This supports the hypothesis that poor sleep quality increases metabolic 
and CVD risk.
In conclusion, there is some evidence that short sleep duration and poor sleep quality have 
unfavourable effects on CVD risk factors. 
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iMPliCaTions for PubliC healTh
The results reported in this thesis underline the importance of a healthy diet, sufficient physical 
activity and sufficient sleep. In The Netherlands, much is to be gained with regard to adhering 
to a healthy lifestyle. The Dutch National Food Consumption Survey of 2007–2010 showed that 
only 3–14% of the Dutch adults complied with the recommendations for vegetable consumption, 
only 3–26% with those for fruit, and 10–33% with those for fish consumption.57 The situation is 
more favourable for physical activity, 58% of the adults adhered to the Dutch physical activity 
guideline in 2011.58 Average sleep duration was 8 hours for men and 8.5 hours for women aged 
25–64 in 2003.58 As far as we know, there are no representative data on prevalence of short or 
long sleep duration or poor sleep quality in The Netherlands. Alcohol was consumed by 84% 
of persons aged between 15–65 in 2008.59 Furthermore, 25% of the Dutch population above 
the age 15 smoke.60 
From a public health perspective, both the prevalence of unhealthy lifestyle factors, and the 
association with health outcomes are of interest. The population attributable risk (PAR) combines 
these two into a measure that can be interpreted as the proportion of the disease that could 
have been prevented if the unhealthy lifestyle factor would not have been present. In other 
words, the PAR gives an estimate of the reduction in CVD incidence that would be observed if 
the total population adhered to a healthy lifestyle, compared to the current level of the lifestyle 
factors.61 This is under the assumption of a causal association between lifestyle factors and CVD 
incidence. For the calculation of PARs, we used the prevalence of lifestyle factors and the HRs 
for the associations of these lifestyle factors with 12-year CVD incidence as reported in this 
thesis. Subsequently, we translated PARs into the number of composite CVD cases that could 
have been prevented in the total population of The Netherlands – considering that 92,602 cases 
occurred in 200762,63 (Table 7.2). 
In the MORGEN Study, we defined five healthy lifestyle factors: a healthy diet (Mediterranean 
Diet	Score	≥5),	sufficient	physical	activity	(≥3.5	hrs/wk	cycling	or	sports),	sufficient	sleep	duration	
(≥7	hours),	alcohol	consumption	(≥1	beverage/month),	and	non-smoking	(Chapter	6).	According	
to these definitions, 37% of the MORGEN cohort had a healthy diet, 52% sufficient physical 
activity and 83% sufficient sleep duration (Table 7.2). The number of composite CVD cases that 
could have been prevented yearly in the total population of The Netherlands by a healthy diet, 
or sufficient physical activity, or sufficient sleep duration were 7,300 (8%), 6,200 (7%), and 4,100 
(4%), respectively. If the whole population would adhere to all three healthy lifestyle factors 
13,900 (15%) cases could have been prevented or postponed. If – in addition to these three 
lifestyle factors – the whole population would also adhere to moderate alcohol consumption 
and did not smoke 33,300 (36%) CVD cases could have been prevented or postponed (Table 
7.2). It should be noted that PARs should be interpreted with caution because they are based 
on point estimates with substantial confidence intervals of the prevalence of lifestyle factors 
and of the HRs for the association between these lifestyle factors and CVD incidence. These 
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figures therefore give only an indication about the possible effect of optimalisation of lifestyle 
factors on CVD risk.
Since the prevalence of lifestyle factors is population specific, preventable proportions are too. 
In the MORGEN Study, participants were younger and healthier than the total Dutch population, 
and therefore the prevalence of healthy lifestyle factors may be higher.64 Since the proportion 
of the MORGEN population that can improve their lifestyle is smaller than in the general 
Dutch population, this may have resulted in an underestimation of the PAR for the general 
Dutch population. Consequently, the number of CVD cases that could have been prevented or 
postponed may be underestimated. For instance, the Dutch National Institute for Public Health 
and the Environment (RIVM) concluded in their report ‘Our Food Our Health’ that if all Dutch 
people would adhere to the dietary guidelines, 38,100 fatal and non-fatal CVD cases could have 
been prevented or postponed (24%).65 For adhering to the Dutch physical activity guideline the 
corresponding number of cases was 20,700 (13%), for alcohol consumption 16,400 cases (10%), 
and for non-smoking 24,000 (15%) cases.65 These numbers are larger than those estimated 
based on the MORGEN cohort. This difference is due to larger PARs in ‘Our Food Our Health’ 
due to different operationalisation of a healthy lifestyle and cut-off points for a healthy level. 
In addition, a difference in definition of the CVD endpoints resulted in lower estimates of the 
numbers of cases that could have been prevented. We used a composite of fatal total CVD, 
non-fatal stroke and CHD, whereas in the report a composite of fatal and non-fatal CHD, stroke 
Table 7.2 Public health impact of lifestyle factors on composite CVda: the MorGen study 
Lifestyle factor Prevalence 
(%)
Hazard ratio PAR 
(%)b
Number attributable 
to lifestyle factor(s) in 
The Netherlandsc
Healthy dietd 37 0.88 (0.74–1.05) 8 7,300
Sufficient physical activitye 52 0.87 (0.74–1.03) 7 6,200
Sufficient sleepf 83 0.78 (0.65–0.94) 4 4,100
All three above factors 19 0.75 (0.58–0.97) 15 13,900
Moderate alcohol consumptiong 84 0.79 (0.63–0.98) 4 3,900
Non-smoking 65 0.57 (0.48–0.67) 21 19,200
Five healthy lifestyle factorsh 12 0.35 (0.23–0.52)i 36 33,300
a Composite of fatal CVD, nonfatal myocardial infarction and nonfatal stroke; b Proportion of the cases that 
could have been prevented or postponed if all participants adopted all healthy lifestyle factors; c Considering 
that in The Netherlands 92,602 composite CVD cases occured in 2007,62,63 numbers were rounded to the 
nearest 100; d A healthy diet was defined as a Mediterranean Diet Score of 5–8 (range 0–8); e Sufficient 
physical	activity	was	defined	as	≥3.5	hrs/wk	cycling	and	sports;	f Sufficient sleep duration was defined as 
≥7	hrs;	g Alcohol	consumption	was	defined	as	≥	one	glass	per	month; h Five healthy lifestyle factors: healthy 
diet, sufficient physical activity, sufficient sleep duration, moderate alcohol consumption, and non-smoking; 
i Hazard ratio for five compared to none or one healthy lifestyle factors
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and heart failure was used.65 In other cohort studies on lifestyle factors in relation to CVD risk, 
preventable proportions of CVD incidence for adhering to all lifestyle factors ranged from 35% 
to 80%66-80 so our estimation of 36% may be considered conservative.
ConClusions
Our results suggest that the strength of the association between dietary patterns and CVD 
incidence is likely underestimated in studies in which only the baseline measurement of diet 
was used. Furthermore, leisure time physical activities should be of at least moderate intensity 
to contribute to a lower CVD risk. We also observed that sufficient sleep is a factor that should 
be taken into consideration in CVD prevention, in combination with a healthy diet, sufficient 
physical activity, moderate alcohol consumption and not smoking. We estimated that about a 
third of CVD cases could have been prevented or postponed by adhering to a healthy lifestyle. 
Our results underscore the importance of a healthy lifestyle for CVD prevention.
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Dit proefschrift richt zich op de associatie tussen leefstijl en hart- en vaatziekten (HVZ). De 
nadruk ligt hierbij op het voedingspatroon, lichaamsbeweging en slaapgewoonten. HVZ is de 
verzamelnaam voor aandoeningen van het hart- en vaatstelsel, zoals hartinfarcten en beroertes. 
Hoewel de sterfte aan HVZ in Nederland afneemt, neemt het aantal bestaande ziektegevallen toe.
Er is in de afgelopen tientallen jaren veel onderzoek gedaan naar leefstijl in relatie tot hart- en 
vaatziekten. Het is bekend dat een gezond voedingspatroon, voldoende lichaamsbeweging, 
matige consumptie van alcohol en niet-roken het risico op HVZ kunnen verlagen met ongeveer 
twee derde. Onderzoek naar de associatie tussen slaap en HVZ staat nog in de kinderschoenen. 
In dit proefschrift zijn de volgende vraagstellingen onderzocht:
•	 Wat is de associatie tussen een Mediterraan voedingspatroon en verschillende 
vormen van HVZ? (Hoofdstuk 2)
•	 Wordt de effectschatter van de associatie tussen een Mediterraan voedingspatroon 
en HVZ sterker door meerdere metingen van dit voedingspatroon te gebruiken? 
(Hoofdstuk 3)
•	 Wat is de associatie tussen specifieke vormen van lichaamsbeweging (wandelen, 
tuinieren, fietsen en sporten) en HVZ? (Hoofdstuk 4)
•	 Hoe zijn slaapduur en slaapkwaliteit geassocieerd met HVZ? (Hoofdstuk 5)
•	 Voegt voldoende slapen iets toe aan de verlaging van het risico op HVZ die al 
bereikt is door een gezond voedingspatroon, voldoende lichaamsbeweging, een 
matige consumptie van alcohol en niet-roken? (Hoofdstuk 6)
Om antwoord te geven op de vraagstellingen is gebruik gemaakt van de gegevens van het 
EPIC-NL cohort, het MORGEN cohort, en de Doetinchem Cohort Studie. Voor onze analyses 
in het EPIC-NL cohort (hoofdstuk 2) zijn bijna 35.000 mannen en vrouwen van 20–65 jaar 
geselecteerd. Bij deze mensen zijn in de periode 1993–1997 leefstijl- en risicofactoren gemeten. 
Meer dan 20.000 van die deelnemers in EPIC-NL waren onderdeel van het MORGEN cohort 
(hoofdstukken 2, 4 en 5). Voor het MORGEN cohort zijn aselecte steekproeven getrokken 
uit de bevolkingsregisters in Amsterdam, Maastricht en Doetinchem. Voor de analyses in de 
Doetinchem Cohort Studie is gebruik gemaakt van drie herhaalde metingen over een periode 
van 10 jaar bij ongeveer 3.400 mensen uit Doetinchem.
De mate waarin volgens het Mediterrane voedingspatroon wordt gegeten, wordt vaak gemeten 
met een Mediterrane voedingsscore die van 0–9 loopt. In het EPIC-NL cohort is onderzocht hoe 
het verband tussen de Mediterrane voedingsscore voor verschillende HVZ er uit ziet (hoofdstuk 
2). Dat deze score geassocieerd is met een lager risico op HVZ is in meerdere prospectieve cohort 
studies aangetoond. Echter, HVZ is een verzamelnaam van ziektebeelden met verschillende 
oorzaken (etiologie). Elke toename van twee punten op de score ging gepaard met een 22% 
lager risico op sterfte aan HVZ en een 5% lager risico op totaal (ziekte + sterfte) HVZ. Voor 
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de specifieke HVZ, was elke toename van twee punten op de score gerelateerd aan een 14% 
lager risico op een hartinfarct, een 12% lager risico op beroerte en een 26% lager risico op 
longembolie. Angina pectoris, TIA, en perifeer arterieel vaatlijden lieten geen verband zien met 
de Mediterrane voedingsscore. Dit is mogelijk een gevolg van het feit dat deze aandoeningen 
minder makkelijk vast zijn te stellen dan die van hartinfarct, beroerte en longembolie.
In de Doetinchem Cohort Studie is de associatie tussen de Mediterrane voedingsscore en 
HVZ op basis van één meting van de Mediterrane voedingsscore aan het begin van de studie 
vergeleken met dezelfde associatie op basis van het gemiddelde van drie metingen over 
een periode van 10 jaar (hoofdstuk 3). Herhaalde metingen kunnen de meetfout verkleinen 
aangezien een gemiddelde blootstelling van meerdere metingen een kleinere variatie binnen 
personen geeft. Daarnaast kan door het gebruik van herhaalde metingen rekening worden 
gehouden met mogelijke veranderingen in eetgewoonten in de tijd. Zoals verwacht is de 
associatie van HVZ met de eenmalige meting van het Mediterrane voedingspatroon minder sterk 
dan die met het gemiddelde van drie metingen. In welke mate dit komt door het verminderen 
van de meetfout of door mogelijke veranderingen in eetgewoonten is niet duidelijk. Onze 
resultaten laten zien dat de sterkte van de associatie tussen de Mediterrane voedingsscore 
en HVZ mogelijk onderschat wordt in onderzoeken met slechts één meting van deze score. 
In het MORGEN cohort is de associatie tussen specifieke vormen van lichaamsbeweging 
en HVZ onderzocht (hoofdstuk 4). Fietsen (wel versus niet) en sporten (wel versus niet) zijn 
geassocieerd met respectievelijk een 18 en 26% lager risico op HVZ. In onze studie zijn wandelen 
en tuinieren niet aan HVZ gerelateerd. Wandelen en tuinieren zijn activiteiten met over het 
algemeen een relatief lage intensiteit. Er was geen informatie over de intensiteit van wandelen 
en tuinieren. Daarom was het niet mogelijk om wandelen en tuinieren met een lage en matige 
intensiteit te scheiden. Dit heeft gezorgd voor misclassificatie en dus voor het mogelijk missen 
van een associatie. Een andere verklaring voor het feit dat er geen associatie voor wandelen en 
tuinieren was, is dat de MORGEN-populatie uit vrij jonge en actieve mensen bestaat. Het zou 
kunnen dat wandelen niet veel meer toevoegt als men al activiteiten met een hogere intensiteit 
uitvoert. Deze hypothese wordt ondersteund door het feit dat in andere – veelal Amerikaanse 
– onderzoeken, met minder actieve deelnemers, vaak wel een associatie tussen wandelen en 
HVZ gevonden wordt.
In het MORGEN cohort is onderzocht of slaapkwaliteit, naast slaapduur, van belang is voor de 
preventie van HVZ (hoofdstuk 5). Andere onderzoeken hebben aangetoond dat zowel een korte 
slaapduur als een lange slaapduur het risico op HVZ verhoogt. Wij vonden bij mensen die kort 
slapen	(≤	6	uur	per	24-uurs	periode)	ten	opzichte	van	mensen	met	een	normale	slaapduur	(7	
uur) een 15% hoger risico op totaal HVZ en een 23% hoger risico op coronaire hartziekten. Er 
zijn echter mensen die kort slapen maar ’s ochtends wel fris en uitgerust opstaan. Waarschijnlijk 
combineren deze mensen een korte slaap met een goede slaapkwaliteit. Kort slapen en een 
slechte slaapkwaliteit was geassocieerd met een 65% hoger risico op totaal HVZ en een 85% 
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hoger risico op coronaire hartziekten ten opzichte van een normale slaapduur en een goede 
slaapkwaliteit. Bij alléén een korte slaapduur (maar goede slaapkwaliteit) of alléén een slechte 
slaapkwaliteit (maar normale slaapduur) was het risico op totaal HVZ en coronaire hartziekten 
wel verhoogd, maar niet statistisch significant. Wij zagen geen verhoogd risico op totaal HVZ 
en	coronaire	hartziekten	bij	mensen	met	 lange	slaapduur	(≥	9	uur	per	24-uurs	periode),	 in	
tegenstelling tot andere cohortstudies. Onze conclusie was dat een korte slaapduur het sterkst 
geassocieerd was met HVZ in combinatie met een slechte slaapkwaliteit. Wij bevelen daarom 
aan om in toekomstig onderzoek niet alleen slaapduur, maar ook slaapkwaliteit mee te nemen.
Vervolgens is in het MORGEN cohort onderzocht of voldoende slapen iets toevoegt aan 
de verlaging van het risico op HVZ door traditionele gezonde leefstijlfactoren – een gezond 
voedingspatroon, voldoende lichaamsbeweging, matig alcoholgebruik en niet-roken (hoofdstuk 
6). Mensen die gezond eten, voldoende bewegen, matig alcohol gebruiken en niet-roken hadden 
een 57% lager risico op totaal HVZ en een 67% lager risico op sterfte aan HVZ ten opzichte 
van de mensen met hoogstens één van deze gezonde leefstijlfactoren. Als de mensen met een 
gezonde leefstijl ook nog voldoende sliepen, hadden ze zelfs een 65% lager risico op totaal HVZ 
en een 83% lager risico op sterfte aan HVZ. Onze conclusie was dat voldoende slaap een extra 
bijdrage levert aan de verlaging van het risico op HVZ door de vier traditionele leefstijlfactoren. 
In hoofdstuk 7 worden de belangrijkste bevindingen van dit proefschrift, enkele methodolo-
gische aspecten, en het effect van de leefstijlfactoren op biologische risicofactoren voor HVZ 
bediscussieerd. Dit hoofdstuk wordt afgesloten met een discussie over de implicaties van onze 
resultaten voor de volksgezondheid met betrekking tot HVZ. Ongeveer één op drie gevallen 
van HVZ zou voorkomen of uitgesteld kunnen worden door een gezonde leefstijl. De resultaten 
in dit proefschrift onderschrijven het belang van een gezonde leefstijl voor preventie van HVZ.
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wist je altijd tijd voor mijn vragen vrij te maken. Astrid, jij ook ontzettend bedankt voor al je 
hulp en voor je vriendschap. Ik ben blij dat je mijn paranimf wil zijn! Als iemand weet hoe het 
is om met een dikke buik op het podium te staan… ;) Julia, bedankt voor het delen van mijn 
enthousiasme over het onderwerp slaap. Jouw kennis en kunde hebben sterk aan het prachtige 
slaapartikel in dit proefschrift bijgedragen. Beste Hendriek, bedankt voor je statistische adviezen, 
in het bijzonder voor het ‘herhaalde-metingen’ artikel. Beste Bas, Jolanda, Yvonne en Joline, 
bedankt voor het gebruik van de data en voor de vele nuttige adviezen. Renate, bedankt voor 
de mooie lay-out. Wat werk jij snel en precies zeg! Marjan en Mark, ontzettend bedankt voor 
het ontwerpen van de mooie kaft! Kitty, wat een leuke poppetjes! Bedankt!
De leden van de leescommissie, de hoogleraren Frans Kok, Eus van Someren en Maria Hopman, 
dank ik voor het beoordelen van de kwaliteit van het manuscript en voor het opponeren. Dear 
Professor David Jacobs, thank you for reviewing my thesis and coming all the way from Minnesota 
for my thesis defence. It is an honour to have you as an opponent.
Ik heb een zeer gezellige en leerzame tijd gehad bij PZO. Het moet gezegd worden dat iedereen 
bij PZO enorm bereid was mij met elke vraag te helpen. Alle deuren stonden altijd wagenwijd 
open. Ontzettend bedankt voor de gezellige werksfeer en de leuke gesprekken! PZO heeft als 
familie gevoeld, en ik ga jullie ontzettend missen! Hoewel ik hier eigenlijk geen namen durf 
te noemen omdat het ondoenlijk is iedereen te noemen, wil ik toch een paar mensen in het 
bijzonder noemen. Peter, bedankt voor je humor, je relativeringsvermogen, je onvoorwaardelijke 
steun en je wijsheid. Ik heb nog steeds 26 jaar… Moniek, wat vond ik het jammer dat je wegging! 
Dankwoord_Marieke.indd   112 18-1-2013   15:02:09
D
ankw
oord
113
Ik ben blij dat je nu je plekje gevonden hebt. Susan, hoewel onze culinaire interesses enigszins 
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bedankt voor het managen van de MORGEN data, de uitgebreide databeschrijvingen en als ik 
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SAS te worden als jij bent. Tot die tijd ben ik blij dat ik veel van je heb mogen leren. Bedankt 
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wat was het fijn dat we elke 14 dagen op jou konden rekenen! Dries, bedankt dat we jouw 
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Mama en papa, bedankt dat ik nog altijd bij jullie mag ‘thuiskomen’. Jan Hendrik en Marit, mijn 
gezinnetje, voor jullie was deze promotie ook een hele investering. Lieve Jan Hendrik, bedankt 
voor je warmte, geduld, rust en perspectief, maar vooral voor je liefde en vertrouwen. Marit, 
lieve vrolijke meid, helaas ben je net zo eigenwijs als je moeder, maar met jou erbij ben ik elke 
dag een bofkont!
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